[{"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "13 units", "code_info": "Rx #'s:C0406509  C0404925  C0405367  C0399957  C0399948  C0398336  C0403450    C0405679  C0409032  C0398683  C0399922  C0404944", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DIAZEPAM (IM/IV) 1MG/ML INJECTABLE 40 ML,\t60 ML; DIAZEPAM (IM/IV) 5MG/ML INJECTABLE 2 ML, 20 ML,\t300 ML; DIAZEPAM 2.5MG/ML INJECTABLE 40 ML; DIAZEPAM 2MG/ML INJECTABLE 100 ML, 50 ML (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1501-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0397447", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "GANCYCLOVIR, SDPF - (30G, 1/2\" SYRINGE) 20MG/ML INJECTABLE 1 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1526-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Alpharetta", "address_1": "5770 Shiloh Rd", "reason_for_recall": "Failed USP Dissolution Test Requirements: Out of Specification dissolution result at 18 month time point", "address_2": "", "product_quantity": "7230 bottles", "code_info": "Lot number: 2021956, Exp; 01/2013", "center_classification_date": "20120626", "distribution_pattern": "PA", "state": "GA", "product_description": "Nisoldipine Extended Release Tablets, 17mg, 100 count bottle, Rx only,  Manufactured for: Prasco Laboratories Mason OH 45040, Manufactured by SkyePharma production SAS 38297, Saint Quentin-Pallavier, France, NDC: 0677-1979-01", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Shionogi Inc.", "recall_number": "D-1398-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62004", "termination_date": "20130207", "more_code_info": "", "recall_initiation_date": "20120308", "postal_code": "30005-8408", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "17 units", "code_info": "Rx #'s:  0378831    0387603    0391286    0391286      0391286    0396237    0391286      0401965    0392266      0406349    0360543    0406198    0360543    0398555", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ETHYL ALCOHOL 10% INJECTABLE 30 ML; ETHYL ALCOHOL 100%INJECTABLE 10 ML, 100 ML, 20 ML, 40 ML, 5 ML, 60 ML; ETHYL ALCOHOL 20% INJECTABLE 5 ML; ETHYL ALCOHOL 5% INJECTABLE 180 ML, 30 ML;  ETHYL ALCOHOL 95% INJECTABLE 10 ML, 8 ML; ETHYL ALCOHOL OPHTHALMIC 40% INJECTABLE 50 ML (13 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1516-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "19 units", "code_info": "Rx #'s:  0388808,  0406214,  0388808,  0406214,  0388808,  0388808,  0388808,  0406214,  0400763,  0402158,  0393558,  0393558,  0394256", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ASCORBIC ACID (BEET SOURCE) 500MG/ML INJECTABLE 100 ML, 150 ML, 200 ML, 250 ML, 300 ML, 400 ML, 500 ML, 60 ML; ASCORBIC ACID (CORN SOURCE) 500MG/ML INJECTABLE 100 ML; ASCORBIC ACID, 50ML SDPF, VIAL** 500MG/ML INJECTABLE 50 ML, 500 ML; ASCORBIC/B1/B2/B3/B5/B6/B12/METHIONINE/INOSITOL/CHOLINE/LIDO  INJECTABLE 40 ML, 50 ML, 60 ML (14 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1457-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #'s:   0407246    0365303    0387896", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PILOCARPINE HCL P.F IN  B.S.S OPHTHALMIC  1% INJECTABLE\t36 ML;  PILOCARPINE HCL SOLUTION  0.5% OPHTHALMIC\t30 ML;  PILOCARPINE HCL SOLUTION (PF) 0.5% OPHTHALMIC\t30 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1602-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #'s:  0397741    0402847    0396295      0394438", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CLINDAMYCIN OPHTHALMIC (PF) 20MG/ML (2MG/0.1ML) SOLUTION\t2 ML;  CLINDAMYCIN PHOSPHATE OPHTHALMIC, INTRAVITREAL (P.F.) 1MG/0.1ML INJECTABLE 0.2 ML; CLINDAMYCIN PHOSPHATE SDPF- (0.1ML SYRINGE,30G,1/2\") 1MG/0.1ML INJECTABLE\t0.1 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1486-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Somerset", "address_1": "265 Davidson Ave Ste 300", "reason_for_recall": "Labeling: Presence of Undeclared Color Additive; The product is being recalled because several inactive ingredients were not included in the labeling for this product: Undeclared D&C Red #33, FD&C Blue #1, Titanium Dioxide Suspension, Purified Water USP.", "address_2": "", "product_quantity": "478,569 Softgel Capsules (172,740 trade plus 305,829 samples).", "code_info": "Lot 249814 Samples  Lot 249816 samples  Lot 260393 exp 4/30/20012  Lot 255345 exp 11/30/2011  Lot 000001 exp 8/31/2012  Lot 261827 exp 5/31/2012  Lot 50004 exp 11/30/2012  Lot 50005 exp 11/30/2012  Lot 500007 exp 12/31/2012  Lot 000002 exp 9/30/20012", "center_classification_date": "20120713", "distribution_pattern": "Nationwide", "state": "NJ", "product_description": "Prefera OB One Gel Capsules, 30 softgels, Rx Only, Manufactured by: IVC industries, Inc. Irving ton, NJ 07111, For: Alaven Pharmaceutical LLC Marietta, GA 30062, NDC 68220-086-30", "report_date": "20120725", "classification": "Class II", "openfda": {}, "recalling_firm": "Meda Pharmaceuticals Inc.", "recall_number": "D-1418-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61683", "termination_date": "20170208", "more_code_info": "", "recall_initiation_date": "20111017", "postal_code": "08873-4120", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "16 units", "code_info": "Rx #'s:    0407245    0405512    0390573    0401816    0391676    0392234    0388024    0405512    0391676    0362742          0362742", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PHENYLEPHRINE HCL IN BSS - P.F. OPHTHALMIC 1% INJECTABLE\t35 ML;  PHENYLEPHRINE HCL, 1ML VIAL*** 1% (10MG/ML) INJECTABLE\t1 ML  \t10 ML  \t  \t25 ML  \t  \t5 ML  \t  \t50 ML;  PHENYLEPHRINE, STSL, P.F. (0.5ML SYRINGE, SLIP-TIP, NO NEEDLE) 1.25% INJECTABLE\t5 ML  \t  \t  \t  \t7.5 ML  (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1599-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62350", "recalling_firm": "sanofi-aventis US, Inc.", "address_1": "Route 202-206", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1407-2012", "product_description": "Eloxatin (OXALIplatin injection) 5 mg/mL Injection, 50 mg, Rx only, Mfd. for: sanofi aventis US LLC Bridgewater, NJ 08807, NDC 0024-0590-10", "product_quantity": "196,355 vials", "reason_for_recall": "CGMP Deviations:  Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues in Good Manufacturing Practices.", "recall_initiation_date": "20120206", "center_classification_date": "20120705", "termination_date": "20131203", "report_date": "20120711", "code_info": "Lot number and expiration dates    Eloxatin\u00bf (OXALIplatin injection) 50mg vial AE41 02/ 2012   Eloxatin\u00bf (OXALIplatin injection) 50mg vial CA02B 02/ 2012   Eloxatin\u00bf (OXALIplatin injection) 50mg vial AE27 02/ 2012   Eloxatin\u00bf (OXALIplatin injection) 50mg vial BL18B 06/ 2012   Eloxatin\u00bf (OXALIplatin injection) 50mg vial CB13B 06/ 2012   Eloxatin\u00bf (OXALIplatin injection) 50mg vial CD65B 01/ 2014   Eloxatin\u00bf (OXALIplatin injection) 50mg vial CE39B 01/ 2014"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "26 units", "code_info": "Rx #'s:   0387528    0395197    0389191      0390909    0406810    0409865    0388591    0388594    0388595    0388597    0388598    0388599    0388602    0388604    0391126    0390909      0390909        0397860    0400856    0402992    0404849    0406843", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DIPHENHYDRAMINE  25MG/ML INJECTABLE 90 ML; DIPHENHYDRAMINE 50MG/ML INJECTABLE 10 ML, 100 ML, 108 ML, 120 MLS, 25 ML, 32 ML, 60 ML, 90 ML, 90 MLS; DIPHENHYDRAMINE, SDV, 25X1ML** 50MG/ML INJECTABLE 25 ML (11 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1503-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "28 units", "code_info": "Rx #'s:  0388316    0388963      0389126    0389635    0391611      0406215    0395252    0392864    0395978    0390748    0390748          0390748    0391630    0391630    0390748    0400319    0388489    0388489    0389320    0390209    0403997    0382211    0381428", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "EDTA  DISODIUM SOLUTION 33.6MG/ML (0.1 MOLAR) OPHTHALMIC 15 ML;  EDTA CALCIUM DISODIUM (PRESERVATIVE FREE) 150MG/ML INJECTABLE 100 ML, 2400 ML, 500 ML; EDTA CALCIUM DISODIUM SOLUTION  2% OPHTHALMIC 5 ML; EDTA DISODIUM (P.F.) 150MG/ML INJECTABLE 1000 ML, 1200 ML, 1500 ML, 400 ML, 500 ML, 900 ML; EDTA DISODIUM (PRESERVATIVE FREE) 150MG/ML INJECTABLE 1000 ML, 2000 ML, 8000 ML;  EDTA DISODIUM (PRESERVATIVE FREE) 3%/ML INJECTABLE 12 ML; EDTA DISODIUM IN NATURAL TEARS  1.5% OPHTHALMIC 5 ML; EDTA DISODIUM IN NATURAL TEARS  3% OPHTHALMIC 15 ML,\t 30 ML (18 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1512-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:  0397883    0353267    0408663    0400621      0400621", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "POTASSIUM CHLORIDE ***(30ML VIAL) 2MEQ/ML INJECTABLE\t750 MLS;  POTASSIUM CHLORIDE IN NORMAL SALINE 40MEQ/100ML (400MEQ/L) INJECTABLE\t1000 ML;  POTASSIUM CHLORIDE**(25X20ML) 2MEQ/ML  INJECTABLE\t500 ML;  POTASSIUM PHOSPHATE 4.4MEQ/ML (3MMOL/ML) INJECTABLE\t300 ML  \t  \t750 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1603-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "63 units", "code_info": "Rx #'s:   0386512    0388165    0390153    0392066    0392315    0392317    0384766          0392082    0392094    0379483    0385383      0393729          0397989      0398600      0406470    0407865    0407875    0409041    0410198    0386262    0399600      0386262    0408795    0395274    0395279    0395285    0376062      0389403    0399790    0400511      0400527    0401472      0402407    0402536      0403638    0406466    0406692    0407272    0405789    0394350      0402541        0394350        0392062    0392062", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "SERMORELIN ACETATE, LYOPHILIZED 6MG KIT\t1 KIT  \t  \t  \t  \t  \t  \t2 KIT;  \t  \t  \t  SERMORELIN ACETATE, LYOPHILIZED 6MG VIAL\t2 VIAL;  \t  SERMORELIN ACETATE, LYOPHILIZED 9MG KIT\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t3 KIT  \t  \t  \t6 KIT;  SERMORELIN ACETATE, LYOPHILIZED 9MG VIAL\t1 VIAL  \t2 VIAL  \t  \t  \t3 VIAL  \t  \t30 VIAL;  SERMORELIN ACETATE/GHRP 2,6 - LYOPHILIZED 9MG/3.15MG/3.15MG KIT\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t3 KIT;  SERMORELIN ACETATE/GHRP 2,6 - LYOPHILIZED 9MG/3.15MG/3.15MG VIAL\t1 VIAL  \t  \t  \t  \t  \t3 VIAL  \t  \t  \t4 VIAL  \t7 VIAL  (16 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1616-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #:  0383354", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYALURONIDASE/METHYLPREDNISOLONE ACETATE, P.F. 37.5U/20MG/ML INJECTABLE 20 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1537-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:   0387816    0387171    0387357    0401493    0372169    0401493      0401493", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE/TETRACAINE OPHTHALMIC 4%/0.5% SOLUTION\t10 ML  \t15 ML  \t20 ML  \t200 ML  \t240 ML  \t300 ML  \t  \t400 ML  (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1563-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1603 units", "code_info": "Rx #'s:   0370964      0392699    0399999    0388807    0373823        0407907    0408836    0409758    0368890    0396425    0404388      0390568    0393084    0390568    0353060    0390096        0369563      0356202    0399491    0377731    0365263      0398599    0400417    0409104    0381235    0355859    0371377    0402545    0371377    0404586    0359139    0375269    0380498    0390885    0371652    0371652          0370384    0390476    0357298    0381009      0389478    0400908        0391406      0388541          0390476    0389352      0403385    0390300    0391406    0380532    0371606    0392256        0364156        0402994    0407589    0369206      0378697      0388874      0391939    0399751      0409764    0357230            0401215        0393374    0401252    0403616    0407339    0381249          0393047      0399227    0373040        0410204    0353362    0367634    0380616        0387463      0395032    0396526    0400059    0403263    0403268    0408301    0385463    0409902    0395126      0399133    0401102    0401107    0401651    0403704    0405197    0405760    0406316    0406322    0396285      0403691    0397249    0359198      0407962    0362367    0403023      0405308    0371668        0351463      0355946    0358970    0367278      0368955    0378244      0378494    0381048      0381893    0382831        0389390    0392285    0392879    0394905      0403994      0358379    0375331    0374070    0398377    0368154    0374011    0376715    0382454    0382831    0399423    0399645    0401306        0391641    0402714    0408696    0394497    0409808    0406673      0375182      0393832    0391683    0368348    0375182      0385666        0391426    0367299        0408918    0360740      0375301        0391074    0392376    0397160    0398142    0399608    0402052    0402492      0377170        0385187      0352706    0355092    0356255    0356732    0358621    0363754    0364595      0365070      0365619    0366077    0367690      0369330      0369413    0369770    0371950    0372657        0373473    0374074    0374392      0374730    0374749    0377455      0378324    0379558      0380891    0381211      0382037    0382046    0382986    0383709      0384705    0385187    0386830    0386838    0386841    0387525    0388003      0388219    0388610    0389400      0389613    0389902    0390005    0390119    0390361    0390416    0390575    0390590    0392011    0393375    0393527    0393802    0393821    0394721      0395123    0395253    0395362    0395619    0396264    0396704    0396920    0397032    0397650    0397679    0397931    0398131    0398331      0398696    0399673    0399676    0399926    0400329    0400747    0400874      0401081    0401356    0401580    0402139    0402289    0402383    0402504    0402543    0403355    0403486    0403789    0403798    0403802    0404070    0404189    0404775    0404793    0405117    0405387    0405403    0405643    0405872    0405918    0406134    0406144    0406252    0406389    0406712    0407038    0407237    0407380    0407464    0407479    0407941    0408051    0408630    0408801    0409019    0409021    0409137    0409248    0409681    0409745    0409918    0353075    0377170      0393821    0398665    0401094    0407571    0366685      0410242    0381447    0382347    0399747    0402383    0367834      0382756      0385041    0406641    0406741    0352749    0362161    0363543    0365973      0366062      0370030    0371579          0373491    0374377    0374749      0375400    0376274    0376650        0377613    0377756        0379507        0379766    0380749    0382500    0384286    0385041    0385187    0386025      0386153          0386315    0386401    0388556    0389501    0389584    0390924    0391308    0391593            0391721    0393171      0393193    0393470    0393669    0393752    0393993    0394102    0394158      0394780    0395464    0396003    0396807    0397514    0397845    0398082    0398120    0398157    0399466    0400076    0400747    0400994    0401283    0401391    0401852    0401983    0402284    0402611      0403016    0403414    0403797      0404866    0404898    0404908    0405390    0405420    0405999    0406556    0406569    0408171    0409272    0401125    0405089    0382347      0398891    0404891    0409279    0387983      0364714    0369832    0399010    0403415    0379074    0387649    0394705      0397102    0397315    0362465    0404557    0353244    0405761    0361584    0364611    0371055      0381231    0381963    0382957    0387867    0390079    0390103    0393067    0396875    0397590    0399060    0400458    0401399    0401840      0402783    0403198    0404246    0404367    0404421    0405259    0406450    0407058    0364670      0390408        0409519    0403276    0369241      0410377    0408734    0394080    0386949    0394080    0350278    0358363    0360732    0362193    0367614    0378564    0379488      0385896      0386949    0387277    0387639    0388526      0392373      0396939    0397133    0397688    0398684    0399909    0400497    0400949    0401212    0401399    0402230      0402905    0402941      0403622    0404180      0404404    0404717    0406327    0406592    0407801    0408526    0381963    0401820    0400295    0385464    0392330    0385464    0395215    0360252    0373883    0391666    0392924      0398059    0404946    0404947    0404229    0407881    0356445    0373904    0374588      0376266    0377187      0384452    0388865    0391973    0393277    0396844    0397399      0399233    0399919    0404386    0404475    0388356          0409496    0366411      0372326      0377187      0388932    0389124        0395764    0398549    0366732    0367231    0396533    0396813    0389134      0391530    0401532    0404513    0406403    0379750    0389313    0406696    0408045    0408330    0390919    0368313    0368712    0388796    0394361    0395060      0400660    0401494      0392545    0396348    0387490    0394867    0398714    0405315    0360540    0396750    0396751    0360540    0406192    0396749    0360539      0406191    0392161    0370736    0370760    0370761    0370762    0370800    0403632      0369880    0383841      0350689    0405502    0348975    0401621    0389916    0407178    0393099      0391195    0391858    0392812    0395340    0398698    0401134    0404651    0405304    0407231    0407978    0409571    0410034    0379343        0388182    0388441      0405300    0394920    0383835      0389118    0400140    0391821      0389184    0370948    0378725    0383648    0385151            0386543          0388519    0389803    0395964    0397239    0397773    0392692    0393785    0354435    0392692    0394743    0386063      0378224      0399544    0394366    0389119      0400435    0378196    0376272    0401773    0403650    0400095    0395637    0407732    0376926    0395747    0395105    0363547    0401747    0393444      0397194    0398504    0404949    0370047    0389069    0375921        0357844    0400956    0400956    0381262    0387267    0396029    0403164    0381589        0406317    0351335    0352279    0352654    0352887    0353030    0355228    0355437    0356233    0356461    0356528    0357100    0359134    0359766      0359829    0361123    0361309    0362924    0364728    0364793    0365086    0365454    0365964    0366546      0366812    0366922      0367357    0368219      0369038    0369989    0370277    0371095    0371128    0371218    0371788    0373059    0374079    0374240    0374369    0374696        0375104      0375808    0376148      0376825      0377068    0377917      0378152    0378531    0378578      0378820    0378879    0378938    0379715    0380902    0381458    0382659    0382718    0383637    0383799        0383938      0384023      0385436    0385662    0385834        0386301    0386406      0386822    0386826    0386972    0387046    0387267    0387614    0387617    0387704      0387760        0387802    0387883      0387901    0387949      0387971    0388147    0388177    0388382      0388543    0388640    0388751      0388837    0388902    0388953      0388957    0389035      0389057        0389156    0389188      0389194      0389408    0389457    0389592    0389666    0389717      0389861    0390089    0390170    0390420      0390566      0390656    0390663    0390787    0390813    0390901    0390932    0391073    0391131    0391134    0391137          0391141    0391156    0391213    0391378      0391411    0391590    0391636    0391745    0391767    0391769    0391778    0391780    0391795    0391928    0391980    0392021    0392103      0392109    0392110    0392148    0392253    0392810    0392877    0392986    0393132        0393210      0393225    0393239    0393250    0393348    0393581        0393595    0393765      0394033    0394105    0394167    0394182    0394261    0394353    0394362    0394365    0394370    0394659    0394686    0395067    0395177    0395301    0395353    0395376    0395378    0395418    0395504    0395690    0395707    0395737    0396175    0396190    0396496        0396569      0396649    0396685    0396705    0396766    0396980    0397077    0397117    0397197    0397202    0397233    0397518      0397591    0397677    0397869    0397922    0397950    0398003    0398091    0398151    0398309    0398322    0398329    0398388    0398686    0398777    0398967        0399020    0399225    0399372    0399641    0399838    0399976    0400067    0400201    0400373    0400396    0400432    0400446    0400554    0400610    0400777    0401110      0401124    0401232    0401325    0401372    0401543    0401778    0401894    0401931    0401932    0402048    0402050    0402053    0402126      0402238    0402309    0402342    0402496    0402529    0402532    0402581    0402784    0402958    0402965    0403006    0403040    0403181    0403215    0403223    0403235    0403272    0403578    0403617    0403857    0404019    0404092    0404116    0404179    0404210    0404395    0404489    0404509    0404637    0405045    0405095    0405336    0405434    0405596    0405598    0405653    0405766    0405780    0405837    0405858    0405876    0405974    0405989    0406073    0406087    0406605    0406629    0406985    0406990    0407313    0407602    0407927    0408057    0408073    0408576    0408822    0408838    0408972    0408978    0409203    0409271    0409425    0409842    0410290    0410358    0410359    0387667    0399505    0408717    0388334    0388335    0397436      0371799    0387267        0391583    0392628    0399021    0402758      0405711    0375312    0378419    0378105        0378613    0388331    0389621    0391980    0392110    0392995    0394055    0394362    0395231    0397427    0403422    0353373    0356495    0364728    0387267      0396029    0399256    0410347    0381002    0387758    0390304    0405217    0405218    0405219    0405221    0405222    0407738    0363138    0374618          0402263    0406514    0351046    0353907        0355925    0355926      0357502    0357672    0357926    0358404      0358415    0358511      0359123    0359134          0359561    0359702    0362261    0362309    0363867    0364018    0364229    0364429        0364865    0364992        0365127    0365602      0365757    0366207    0366217    0367041    0367165    0367743    0368197    0368439          0368771    0369163    0369500    0370069    0370627    0371232    0371373    0371788    0372178          0372239    0372266    0372280    0372458    0373421    0373440    0374126    0374551    0375282    0375304      0375312    0375487    0375489    0376282    0376882    0377064    0377585    0377588      0377792    0377989    0378665      0378692    0378772    0379238    0380004    0380020    0380670    0381139    0381482      0382439    0382718      0382853    0384227    0384681          0384917    0385228      0385280    0385372    0385682    0386305    0386325    0386441    0387285        0387423    0387503    0387547      0387730    0387767    0387883    0387926    0388055      0388069    0388075    0388382    0388592    0388618    0388714          0389122    0389154    0389185    0389194    0389243      0389362    0389384      0389387    0389568      0389587    0389612      0389728    0390080    0390314      0390414    0390554    0390559      0390615    0390928    0391065    0391155    0391270    0391589    0391688    0391776    0391839    0391849      0392012    0392218      0392684    0392708    0392784    0392874      0392913    0392919    0393150    0393445      0393556        0393674    0393885    0393954      0394103      0394226        0394269      0394619    0395392    0395559    0395673    0395750    0395817    0395965    0396153    0396726    0396905    0397138    0397224    0397263        0397277    0397357    0397552    0397597    0397869    0397873    0397951    0398374    0398510    0398737    0398785    0398848    0398969    0399043    0399132    0399270    0399291    0399324    0399355    0399397    0399558    0399570    0399769    0399815    0399826    0399913    0400157    0400484    0400803    0400972    0401176    0401201    0401248    0401278    0401331    0401452      0401459    0401519    0401609    0401794    0402061    0402253      0402290    0402682      0402775    0402862        0402914    0402977    0403003    0403205    0403376    0403433    0403476    0403819    0403869    0404024    0404052    0404467    0404504    0404619    0404760    0404761    0405239    0405278    0405299    0405563    0405895    0405936    0406011    0406254    0406257    0406341    0406618    0406620    0406769    0406804    0406894    0406921    0406929    0406958    0407458    0407586    0407755    0408144    0408157    0408200    0408454    0408491    0408644    0408650    0408697    0408770    0408775    0408814    0409160    0409192    0409285    0409389    0409513    0409534    0409543    0409702    0409746    0409937    0410060    0356463      0364721    0398128    0358695      0390090    0395334    0398588    0400260    0402183    0389573    0387868    0364528    0391435    0401281    0379041    0394110          0401953    0397789    0387304      0380828        0399269    0392386    0391113    0399126    0404236    0400626    0391903    0391903    0382810        0403207    0403207    0406057    0406607    0409616    0397662    0393453    0406077    0409838    0409873    0410231    0374253      0387543    0388084    0393997    0401856    0408058    0402296    0377151      0379588    0388900    0399473    0399755    0366554    0377151    0403687    0394456    0400565    0350179    0368608    0368608    0360853    0354352    0370347    0375782    0375705    0391515    0360852      0358054    0364542      0376210    0390255    0391158    0394455      0394832    0350205    0399580    0388757      0382301", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TRIMIX   9MG / 0.3MG /3.3MCG INJECTABLE\t6 ML;  \t  TRIMIX   9MG / 0.3MG /6.6MCG INJECTABLE\t6 ML;  TRIMIX   9MG / 1MG / 10MCG INJECTABLE\t10 ML;  TRIMIX  ((LYOPHILIZED)) - 2ML VIAL 30MG / 1MG / 10MCG INJECTABLE\t10 ML  \t10 VIALS  \t  \t  \t2 ML  \t  \t  \t4 ML  \t50 ML;  TRIMIX  ((LYOPHILIZED)) - 5ML VIAL 30MG / 2MG / 20MCG INJECTABLE\t10 ML;  \t  TRIMIX  ((LYOPHILIZED)) - 5ML VIAL 30MG / 2MG / 40MCG INJECTABLE\t100 ML  \t5 ML  \t75 ML;  TRIMIX  10MG / 0.5MG / 1MCG INJECTABLE\t10 ML;  TRIMIX  10MG / 1MG / 5MCG INJECTABLE\t10 ML;  \t  \t  TRIMIX  10MG/1MG/0.5MCG INJECTABLE\t10 ML;  \t  TRIMIX  12.5MG/0.83MG/8.33MCG INJECTABLE\t10 ML;  \t  TRIMIX  12MG / 1MG / 12MCG INJECTABLE\t10 ML;  TRIMIX  12MG / 1MG / 9MCG INJECTABLE\t10 ML  \t  \t  \t  \t  \t10 MLS  \t20 ML  \t  \t  \t30 ML  \t5 ML;  TRIMIX  12MG/1MG/5MCG INJECTABLE\t10 ML;  \t  \t  \t  TRIMIX  15MG / 1MG / 10MCG INJECTABLE\t3 ML  \t5 ML;  \t  \t  \t  TRIMIX  22.5MG/0.83MG/3MCG INJECTABLE\t10 ML;  TRIMIX  22.5MG/0.83MG/8.33MCG INJECTABLE\t1 ML  \t10 ML  \t  \t  \t  \t  \t  \t  \t15 ML  \t  \t2.5 ML  \t  \t  \t  \t3 ML  \t30 ML  \t  \t  \t5 ML;  \t  TRIMIX  24MG / 1MG / 10MCG  INJECTABLE\t10 ML;  TRIMIX  24MG / 1MG / 18MCG INJECTABLE\t10 ML;  TRIMIX  25MG/ 1MG / 10MCG INJECTABLE\t10 ML;  \t  \t  TRIMIX  28MG / 0.9MG / 37MCG INJECTABLE\t5 ML;  \t  \t  TRIMIX  30MG / 0.1MG / 40MCG INJECTABLE\t10 ML;  TRIMIX  30MG / 0.2MG / 10MCG INJECTABLE\t10 ML;  TRIMIX  30MG / 0.5MG / 10MCG INJECTABLE\t10 ML;  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t120 ML  \t  \t  \t  \t  \t  \t  \t  \t5 ML  \t  \t  \t  \t60 MLS;  \t  \t  \t  TRIMIX  30MG / 0.5MG / 20MCG INJECTABLE\t1.7 ML  \t  \t10 ML  \t50 ML;  \t  \t  TRIMIX  30MG / 0.5MG / 50MCG/ML INJECTABLE\t10 ML;  TRIMIX  30MG / 0.5MG / 5MCG INJECTABLE\t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t5 ML;  TRIMIX  30MG / 10MG / 20MCG INJECTABLE\t5 ML;  TRIMIX  30MG / 10MG / 60MCG INJECTABLE\t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t10 MLS  \t  \t20 ML  \t5 ML;  TRIMIX  30MG / 1MG / 18MCG INJECTABLE\t5 ML;  \t  \t  TRIMIX  30MG / 1MG / 2.5MCG INJECTABLE\t3 ML  \t5 ML;  \t  \t  TRIMIX  30MG / 1MG / 20MCG INJECTABLE\t1 ML  \t  \t  \t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t10 MLS  \t  \t3 ML  \t  \t5 ML;  \t  \t  \t  \t  \t  \t  \t  \t  \t  TRIMIX  30MG / 1MG / 30MCG INJECTABLE\t10 ML  \t  \t  \t5 ML;  \t  TRIMIX  30MG / 1MG / 40MCG INJECTABLE\t10 ML;  \t  TRIMIX  30MG / 1MG / 50MCG INJECTABLE\t10 ML  \t  \t10 MLS  \t100 ML  \t5 ML;  \t  \t  TRIMIX  30MG / 1MG / 5MCG INJECTABLE\t10 ML  \t  \t  \t20 ML  \t5 ML;  \t  \t  TRIMIX  30MG / 2MG / 100MCG INJECTABLE\t20 ML;  TRIMIX  30MG / 2MG / 10MCG INJECTABLE\t10 ML;  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  TRIMIX  30MG / 2MG / 20MCG INJECTABLE\t1 ML  \t  \t  \t  \t  \t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t10 MLS  \t2 ML  \t  \t  \t  \t  \t  \t2.5 ML  \t  \t  \t20 ML  \t  \t  \t  \t3 ML  \t  \t  \t  \t  \t  \t  \t5 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t5 MLS  \t6 ML  \t60 ML;  \t  \t  \t  \t  TRIMIX  30MG / 2MG / 25MCG INJECTABLE\t10 ML;  \t  TRIMIX  30MG / 2MG / 30MCG INJECTABLE\t10 ML  \t  \t  \t  \t10 MLS  \t5 ML;  \t  \t  \t  \t  TRIMIX  30MG / 2MG / 3MCG INJECTABLE\t5 ML;  TRIMIX  30MG / 2MG / 40MCG INJECTABLE\t1 ML  \t1.25 ML  \t  \t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t15 ML  \t  \t2 ML  \t  \t  \t  \t2.5 ML  \t20 ML  \t  \t  \t20 MLS  \t30 ML  \t4 ML  \t40 ML  \t5 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 ML  \t60 ML;  TRIMIX  30MG / 4MG /  3.5MCG INJECTABLE\t10 ML", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1629-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "62530", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-1654-2012", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 30 mg over 9 hours (3.3 mg/hr), 1 patch per pouch, packaged in 30-count patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186; NDC 68968-5555-3.", "product_quantity": "121,530 patches", "reason_for_recall": "Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.", "recall_initiation_date": "20120712", "center_classification_date": "20120817", "termination_date": "20140804", "report_date": "20120829", "code_info": "Lot # 56506, Exp 12/12"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0404272", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PREDNISOLONE ACETATE 10MG/ML INJECTABLE\t10 MLS  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1606-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Weston", "address_1": "2400 N Commerce Pkwy Ste 400", "reason_for_recall": "Tablet Thickness: Recall was initiated due to the presence of one slightly oversized tablet in a bottle of the identified lot.", "address_2": "", "product_quantity": "1,749 Bottles", "code_info": "Lot: 7212558, Exp 12/12.", "center_classification_date": "20120807", "distribution_pattern": "Nationwide", "state": "FL", "product_description": "Meloxicam Tablets, USP, 15 mg, Rx Only, 100 Tablets per Bottle, Manufactured by: Strides Acrolab Ltd., Bangalore-560 076, India, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-3579-1.", "report_date": "20120815", "classification": "Class II", "openfda": {}, "recalling_firm": "Apotex Corp.", "recall_number": "D-1443-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62436", "termination_date": "20130919", "more_code_info": "", "recall_initiation_date": "20120405", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #'s:   0391709    0393510    0390995    0374399    0393816", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "THIOTEPA, LYOPHILIZED 15MG INJECTABLE\t8 VIAL;  \t  THIOTEPA, LYOPHILIZED 30MG INJECTABLE\t4 VIAL  \t8 VIAL;  THIOTEPA, LYOPHILIZED 60MG INJECTABLE\t2 VIAL  (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1626-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0379143    0379249", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PACLITAXEL 6MG/ML INJECTABLE\t500 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1591-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "25 units", "code_info": "Rx #'s:  0402838    0366311      0393844      0405862    0369802    0361586    0362348      0367636      0354323      0361586      0376846    0395405    0401667    0404458    0356814      0372189", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DAPIPRAZOLE OPHTHALMIC 0.5% SOLUTION 10 ML; DAPIPRAZOLE, LYOPHILIZED, OPHTHALMIC KIT 0.5% POWDER 1 KIT, 10 KIT, 2 KIT, 3 KIT, 4 KIT, 6 KIT (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1495-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0395208", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEXTROSE/PROCAINE HCL P.F. 12%/1% INJECTABLE 400 ML ( 1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1500-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Largo", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62405", "recalling_firm": "VistaPharm, Inc.", "address_1": "7265 Ulmerton Rd", "address_2": "", "postal_code": "33771-4809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1416-2012", "product_description": "Hydrocodone Bitartrate & Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mL, a) 15 mL Unit Dose Cups (50 unit dose cups per case), b) 473 mL Bottles, C III, Rx Only, Warning May be habit forming, Manufactured by VistaPharm, Largo, FL 33771, NDC a) 66689-023-50, b) NDC 66689-023-16.", "product_quantity": "a) 949 Cases, b) 188 bottles", "reason_for_recall": "Impurities/Degradation Products: exceeded specification at 3 month stability testing", "recall_initiation_date": "20120530", "center_classification_date": "20120712", "termination_date": "20130522", "report_date": "20120718", "code_info": "Lot #'s a) 251400, Exp 07/13; b) 251500 Exp 07/13.", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:   0410194    0390761", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FUROSEMIDE*** (25X10ML) 10MG/ML INJECTABLE 250 ML; FUROSEMIDE*** (25X4ML) 10MG/ML INJECTABLE 2 VIAL (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1525-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2350 units", "code_info": "Rx #'s:  0359160        0405079      0364389    0364389    0361241    0377683    0377683    0377683                    0377683    0401661    0401661        0401661    0390308    0359300        0404762    0382630    0407996    0361441    0407996    0387326        0398781    0356812    0398781    0356812    0375792    0403341    0375792    0399708    0387144        0399708    0387144    0375792    0353919    0375792    0389701        0357461    0387144    0389701    0397437    0352503    0357461    0377580              0377580    0386958        0386958    0367201    0371279    0371279      0367201    0384322    0371279    0384322    0367201    0384322              0384322            0375486    0375486    0375486    0375486    0390996        0381779    0361290    0391677    0403321    0361290    0403321    0397396    0393484    0401740    0390929    0393759    0384195    0388799    0388805    0393759    0388805    0393484    0387836    0387836    0398119      0350119    0359128    0400639    0353914    0394457    0353914      0382205        0353914    0394457          0382205        0393293    0393299    0393300    0399578    0399598    0390926    0393485    0388801    0393485    0388806    0368969    0368969    0390918    0390918    0390918      0392167      0357998    0402352    0393760    0393760    0356752          0401186      0369338      0380167    0367010            0369225    0384207    0385361      0387698    0394363    0395273    0396614    0398024    0398662    0399938    0403502    0408817      0359129    0367010    0367401    0370758    0370759    0370763    0370767    0370768    0370770    0370778    0370779    0370783    0370785    0374018    0374024    0374028    0374036    0379772    0379773    0379774    0387698    0388817    0396342    0407944    0407945    0407946    0408269    0408741    0408742    0408817    0370141    0370142    0371173    0371773    0373627    0376439    0378889    0378890    0378892    0378894    0378897    0378898    0378899    0382662    0382666    0382667    0382669    0382670    0382674    0382919    0383307    0383314    0383346    0385937      0388305      0396302    0399567    0401360    0407944    0407945    0407946    0407948      0407951      0407955    0408233    0408237    0408242    0408248    0408250    0408251    0408259    0408262    0408264    0408265    0408271    0408272    0408274    0408280    0408281    0408284    0408672    0408673    0408674    0408675    0408676    0408677    0408678    0408679    0408680    0408681    0408682    0408683    0408684    0408685    0409171    0409173    0409188    0409191    0409205    0409207    0409825    0409826    0409827    0409828    0409829    0409830    0409831    0352123    0359738      0376439    0384103    0385937      0388817    0401360    0401986      0367896      0355412    0359738    0360220    0371173      0372305    0372673    0375789      0378673    0388774    0391407    0392221    0396687    0400615    0404394      0409879    0409880    0367896                0354585      0372673        0375616              0376439      0377592    0380869    0388817    0389473    0390204    0391693    0392559    0396781    0397261      0397948      0398535    0399761    0401997      0367896      0349959    0350509    0365293    0367347    0369312    0371910    0372413    0373066    0373071    0375917    0375918    0376390    0378853    0385894    0387469      0387471    0387472    0388125    0388126    0388128    0388133    0388136    0388635    0389211    0389215      0390369    0390839    0390843    0390848    0391153    0391338    0391340    0391763    0391764    0391861    0391864    0392979    0393223      0394391    0394393    0394501    0394502    0394707    0395314    0395316    0396363    0396818    0396827    0396829    0397889    0397893    0398006    0398551    0398553    0399238      0399240    0399488    0399489    0399502    0399891    0399892    0399893    0399894    0401526    0401528    0402863    0403606    0403609    0403611    0403785    0404539    0404540    0405532    0405933    0406247    0375916    0366046      0366486    0378138    0380869    0386460    0388817    0394444    0398535    0401997    0409796    0378138    0398535    0354936    0355412    0359129    0359985    0360220        0363258      0365502        0367016    0367501              0368624        0371173    0372081                0373976              0375616    0377592      0378673            0382974    0383654    0386404    0387739    0388288    0388774    0388785      0389473        0389828    0392521      0392818    0394444    0398535    0402803    0403654    0404459        0405383    0408232    0409453    0350698    0355237    0366486      0368624    0371173    0378138    0384670    0385775    0388288                0391887        0393789    0396687      0388817    0366486    0356702            0359129    0360220      0367016      0375789    0378673      0382974      0384849    0386404      0387740                  0388288    0389473    0390219    0397948    0398337    0398805          0354554    0359129    0388817    0352916    0352996    0354554    0359129      0359985    0361041              0362197      0363258          0365502                0366486    0367016        0367240      0368282            0368624          0371184    0375789    0378583    0378823    0379513      0380679          0382974              0383438    0384676      0384849      0386729                0387024        0387168    0387740    0388154    0388785          0389511    0391887      0392445    0393797        0399912      0400472      0400522      0401225    0405018          0409004    0409245    0379513    0385775          0352372        0361666      0365188          0365502    0366619        0368282    0378583    0378911    0382974    0385549      0387024    0387374    0387420        0389828      0392938    0394683              0397164        0405238    0408232    0349177    0350459    0352916    0354764    0358804        0359985      0363966        0368493    0371184      0378583    0380167    0385014                0385036                          0385549    0387024                0387168    0387334          0387374    0387739        0388080    0388154      0388288    0388561          0389828      0390176        0390219              0391013                0392187            0392445    0393559    0394572        0398217    0401225    0402280      0403944    0405665    0407685    0409157    0380167    0354764    0378583    0387024    0387374    0398602    0379513      0390966    0382620                                    0390262      0390262    0350302    0357190      0360145      0366591                                        0378823    0380999            0383438      0384207                  0384676    0384713    0385014    0385036    0387024                        0387739                      0388561    0391007                  0391265    0391768    0398602    0407622    0409004    0376772          0406033      0351645        0353827      0355623        0360220    0360607            0361078          0361666        0363966    0366600      0366619      0368316        0378911          0380061        0380658    0384676      0384713      0384923      0387739    0390060    0390223    0390262    0392818                              0395368              0397164          0398337    0399928      0402827        0405238    0408166    0408815    0380323    0387420    0380061    0353827    0355819      0357190      0361868          0366591    0373924      0378823    0380999    0383438          0387168      0392868          0395368          0399063        0400380    0405406    0408666    0409004    0361868    0353827    0365737    0365737    0389735    0365737    0365737    0380167    0361666    0387815                          0380167    0357190      0373924        0380999    0388167    0387488    0352821        0352950      0354664      0365296    0366374      0373924        0380658    0384676      0384923        0385412                      0386588                      0388167    0390060        0390223      0390262    0394454    0394514            0396082        0399081      0380323                          0364967        0399540    0402861        0373924    0380167          0380167    0380167        0380167    0380167    0365296      0386588    0408941    0391001    0396063    0396064    0396069    0396072    0396074    0396076    0406966    0367119    0367128    0367144    0367162    0367167    0367168    0368589    0368907    0370072    0370538    0371351    0373487    0376100    0376101    0376102    0376108    0377388    0377390    0377391    0377639    0378635    0378637    0384407      0400209    0408467    0408474    0408482    0408922    0408924    0408926    0408945    0408955    0408957    0408958    0408959    0408960    0408963    0408965    0408968    0408969    0408971    0408973    0408975    0408976    0408979    0408981    0408982    0408985    0408986    0408988    0409360    0409362    0409363    0409365    0409367    0409368    0409370    0409371    0409455    0409456    0409460    0409462    0409466    0409467    0409469    0409470    0409473    0409474    0409475    0409476    0409478    0409479    0409480    0409481    0409482    0409483    0409485    0409486    0409992    0409995    0409996    0409997    0410009    0379496    0379497    0382688    0384407    0394883      0394892      0394894      0367009      0371356    0379346    0384407    0387817          0367009      0395420      0380864    0362676          0391416    0360422            0367009      0368228    0371356        0379166    0379346            0380864        0382774      0386513      0388038    0389912    0390124      0391416      0394138            0400209    0404461    0380864    0368228      0384722      0387051                    0380864      0380864    0350991        0357056    0361676        0365399      0367009    0368228      0377761    0380864    0384722                  0386513          0390124    0394138      0394380        0394654        0368228    0380864    0404786    0390124    0387051    0349046    0349527        0352252      0360448          0364804                0365399    0366800    0368585          0371356        0372632        0375719          0377761    0379346    0380567                    0380758      0380864    0381539                        0384722      0387508    0387817    0389697    0389912    0390124          0390147                      0392169    0393206          0393526    0394312    0394380    0394654    0396688    0402930    0404374    0393206    0387051    0391416    0392169        0363706    0364338    0371356    0382947    0384722          0392169    0406187    0407176      0349333    0362957              0363706    0368581    0370372                              0371356      0377761      0380754      0381076      0382339    0384722      0388038    0389046    0390124    0391060    0392169    0393761    0394015    0394312        0396688      0406070    0380505      0389046    0354566    0356480            0358943    0373161            0399623        0391272    0399623    0391272    0385261    0386746        0385261              0363706    0366800    0366802            0368581      0368585    0371356    0380754          0381539    0382339    0388038                0388856    0389371                    0390147      0393761      0394312    0398208        0380505    0398208    0363706          0363778              0364338                0366802      0368581    0369332      0378667          0381748    0382339            0385261    0388038      0388530                    0388856        0389697      0403307    0405316        0408287    0388856    0361320            0363706          0366802    0381076      0404496    0366802    0381076            0363706      0369332      0381076    0381748    0406528        0389697    0370372    0358943      0368879        0369332                            0370372    0378279    0386285              0386631                        0387440              0389697              0401843        0406187      0409595    0386285    0386631      0368879        0366903      0401843    0378279    0356077              0358943    0366903                    0367878        0378279        0399290            0358943    0366903    0373461                        0386366    0391318        0386239    0386239      0391318    0369515          0381033      0399529            0381033    0369515    0382083                                      0408575    0410038    0408545    0408548    0408549    0408551    0408552    0408556    0408557    0408559    0408561    0408562    0408563    0408564    0408566    0408567    0408568    0408572    0410000    0410003    0410005    0410006    0410010    0410011    0410012    0410013    0410014    0410021    0410023    0410026    0410027    0410032    0410035    0410036    0384698    0374276          0384698                                  0359109        0359109      0385519              0357253    0369326    0371914    0379256    0362070    0389165    0389174    0389559    0390877    0406656    0375624    0389043    0390877    0395563    0398015    0402663    0405680    0409170    0409331    0360751    0363002    0375624    0389165    0389469    0390962    0392527      0393758    0395160    0395382    0396588    0396772    0397371      0406507    0407078    0410316    0349549    0354136    0392052          0392052    0386359    0391609    0391609    0384742                    0390822    0390822    0390822    0385919    0385919    0385919    0390822    0390822        0401752    0401752    0389208      0389208          0353398    0353398    0395793    0395793    0395793      0395793    0408132    0362868    0362868        0408092    0408098    0408104    0408106    0408108    0408109    0408112    0408121    0408123    0408125    0408126    0408127    0408131    0408270    0388851                0390649    0401777    0356392    0380680      0388851    0400670    0384734                          0386866      0367047    0367047    0368258          0387412            0387412                    0389503    0406922    0366709      0384829            0366709      0384845    0357997    0389503    0366709        0389503              0390475          0406922    0402353    0384845    0386279      0387641    0360671    0389503            0387641      0368967    0361445          0405294    0368967      0387641        0389503    0389503    0368967          0369511      0386279            0393604    0369511                  0369511      0393604    0361445    0390391    0390391      0391674    0367965          0374654      0379809        0379812    0379814        0379823      0388302    0388304    0394315    0394316    0394317    0394318    0394319    0394320    0394321    0394322    0394323    0394324    0394325    0394326    0394327    0394328    0394329    0394330    0394331    0394334    0394335    0394336    0394337    0396752    0396755    0396757    0396760    0396761    0396786    0396788    0396791    0396795    0396796    0396799    0396800    0396811    0396812    0396819    0396832    0396834    0396838    0396839    0401284    0401285    0401286    0401287    0401288    0401289    0401290    0401291    0401292    0401293    0401294    0401295    0401296    0401308    0401309    0401311    0401314    0401315    0403881    0403882    0403884    0403885    0403886    0403887    0403888    0403890    0403891    0403892    0403893    0403894    0403895    0403896    0403897    0403898    0403901    0403902    0403903    0403904    0403905    0403907    0403908    0403909    0403910    0409124    0409125    0409126    0409127    0409129    0409131    0379823    0396780    0396793    0396809    0396831    0402979    0404976    0393055      0402979    0358989    0365946              0399776            0404124    0408612    0358989    0360992      0360992            0402979      0360992    0402979    0392886    0353140        0360992    0393055                  0360992    0392202    0355828    0377903              0355828      0393055          0393439    0409335    0393439        0351750    0353140    0355822    0355821      0355822    0355828    0392202    0355903    0355821    0355821    0366633    0392219    0392219    0392219    0366633", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BEVACIZUMAB & DXM, SDPF - (0.06ML SYRINGE, 31G, 5/16\") 25MG/100MG/ML INJECTABLE 0.72 ML; BEVACIZUMAB & DXM, SDPF - (0.06ML SYRINGE, 31G, 5/16\") 25MG/20MG/ML INJECTABLE 3 ML, 4.5 ML;  BEVACIZUMAB & DXM, SDPF - (0.075ML SYRINGE, 30G, 1/2\") 25MG/20MG/ML INJECTABLE 0.225 ML; BEVACIZUMAB & DXM, SDPF - (0.07ML SYRINGE, 30G, 1/2\") 25MG/20MG/ML INJECTABLE 0.07 ML, 1.33 ML, 1.4 ML, 1.47 ML;  BEVACIZUMAB & DXM, SDPF - (0.07ML SYRINGE, 30G, 1/2\") 25MG/40MG/ML INJECTABLE 0.35 ML, 0.7 ML, 1.05 ML; BEVACIZUMAB & DXM, SDPF - (0.07ML SYRINGE, NO NEEDLE) 25MG/40MG/ML INJECTABLE 0.63 ML; BEVACIZUMAB & DXM, SDPF - (0.09ML SYRINGE, 30G, 1/2\") 25MG/20MG/ML INJECTABLE 1.8 ML, 2.7 ML; BEVACIZUMAB & DXM, SDPF - (0.09ML SYRINGE, 31G, 5/16\") 25MG/20MG/ML INJECTABLE 0.18 ML, 0.27 ML,\t0.45 ML, 1.08 ML, 13.5 ML,2.25 ML, 4.5 ML; BEVACIZUMAB & DXM, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 25MG/16MG/ML INJECTABLE 0.3 ML,\t 0.4 ML, 0.5 ML, 1 ML, 1.2 ML, 1.5 ML, 2 ML, 2.5 ML, 5 ML, 7.5 ML; BEVACIZUMAB & DXM, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 25MG/40MG/ML INJECTABLE\t4 ML, 6 ML;  BEVACIZUMAB & DXM, SDPF - (0.1ML SYRINGE, 31G, 5/16\") 25MG/16MG/ML INJECTABLE 2 ML, 2.5 ML; BEVACIZUMAB & DXM, SDPF - (0.1ML SYRINGE, 31G, 5/16\") 25MG/20MG/ML INJECTABLE 0.3 ML, 0.4 ML, 0.5 ML, 0.6 ML, 0.7 ML, 0.8 ML,\t1 ML, 1.5 ML, 55.1 ML, 57.5 ML, 57.6 ML, 58 ML, 7.5 ML;\t  BEVACIZUMAB & DXM, STSL (0.1ML SYRINGE, 30G, 1/2\") 25MG/16MG/ML INJECTABLE 0.3 ML; BEVACIZUMAB & TMC, SDPF - (0.075ML SYRINGE, 30G 1/2\") 25MG/40MG/ML INJECTABLE\t0.075 ML, 0.15 ML, 0.225 ML, 0.375 ML, 0.75 ML, 1.125 ML, 1.5 ML; BEVACIZUMAB & TMC, SDPF  (0.075ML SYRINGE, 30G, 1/2\") 25MG/80MG/ML INJECTABLE 0.45 ML, 0.75 ML; BEVACIZUMAB & TMC, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 25MG/40MG/ML INJECTABLE 0.3 ML, 0.5 ML, 1 ML, 2 ML,\t2.5 ML, 3 ML; BEVACIZUMAB & TMC, SDPF - (0.1ML SYRINGE, NO NEEDLE) 25MG/40MG/ML INJECTABLE 0.5 ML;  BEVACIZUMAB & TMC, SDPF W/ STSL - (0.075ML SYRINGE, 30G, 1/2\") 25MG/80MG/ML INJE 0.375 ML, 0.525 ML, 0.75 ML, 1.125 ML;  BEVACIZUMAB & TMC, SDPF W/ STSL - (0.15ML SYRINGE, 30G, 1/2\") 25MG/40MG/ML INJEC\t0.6 ML, 0.75 ML, 0.9 ML, 1.05 ML; BEVACIZUMAB & TMC, SDPF W/ STSL - (0.1ML SYRINGE, 30G, 1/2\") 25MG/20MG/ML INJECT 0.2 ML, 0.4 ML; BEVACIZUMAB & TMC, SDPF W/ STSL - (0.1ML SYRINGE, 30G, 1/2\") 25MG/40MG/ML INJECT 0.6 ML, 1 ML; BEVACIZUMAB IN ARTIFICIAL TEARS  0.5% (5MG/ML) OPHTHALMIC 5 ML; BEVACIZUMAB, SDPF - (0.05ML SYRINGE, 27G, 1/2\") 25MG/ML INJECTABLE 0.3 ML; BEVACIZUMAB, SDPF - (0.05ML SYRINGE, 30G, 1/2\") 25MG/ML INJECTABLE 0 MLS, 0.05 ML, 0.1 ML, 0.15 ML, 0.2 ML, 0.2 MLS, 0.25 ML, 0.25 MLS, 0.3 ML, 0.3 MLS, 0.35 ML, 0.36 ML, 0.4 ML,\t0.45 ML, 0.5 ML, 0.6 ML, 0.65 ML, 0.7 ML, 0.75 ML, 0.8 ML, 1 ML, 1.2 ML, 1.25 ML, 1.5 ML,1.5 MLS, 1.75 ML, 1.8 ML, 10 ML, 15 ML, 2 ML, 2.25 ML, 2.5 ML, 2.5 MLS, 2.55 ML, 2.6 ML, 3 ML, 3.1 ML, 3.5 ML, 3.6 ML,\t3.65 ML, 3.7 ML, 3.75 ML, 3.96 MLS, 4 ML, 4.5 ML, 5 ML, 5 MLS, 7 ML, 7.2 ML, 7.2 MLS, 7.25 ML, 7.3 MLS, 7.3 VIAL, 7.4 MLS, 7.5 ML; BEVACIZUMAB, SDPF - (0.05ML SYRINGE, 31G, 5/16\") 25MG/ML INJECTABLE\t0.1 ML, 0.15 ML, 0.2 ML, 0.25 ML, 0.3 ML, 0.35 ML, 0.4 ML, 0.5 ML, 0.55 ML, 0.6 ML, 0.65 ML, 0.7 ML, 0.75 ML, 0.8 ML, 0.85 ML, 0.9 ML, 1 ML, 1.1 ML, 1.2 ML, 1.25 ML, 1.5 ML, 1.75 ML, 10 ML, 12.25 ML, 12.5 ML, 13.5 ML, 15 ML, 17.5 ML, 2 ML, 2.25 ML, 2.5 ML, 2.6 ML, 3 ML, 3.5 ML, 3.75 ML, 4 ML, 4.5 ML, 5 ML, 5.05 ML, 6 ML, 6.25 ML, 6.35 ML, 7.5 ML, 8.75 ML; BEVACIZUMAB, SDPF - (0.06ML SYRINGE, 30G, 1/2\") 25MG/ML  INJECTABLE 1.2 ML, 2.88 ML; BEVACIZUMAB, SDPF - (0.06ML SYRINGE, 31G, 5/16\") 25MG/ML  INJECTABLE 1.5 ML, 1.8 ML, 2.4 ML, 3 ML, 3.6 ML, 4.8 ML, 6 ML; BEVACIZUMAB, SDPF - (0.07ML SYRINGE, 30G, 1/2\") 25MG/ML INJECTABLE 1.75 ML; BEVACIZUMAB, SDPF - (0.07ML SYRINGE, 31G, 5/16\") 25MG/ML INJECTABLE\t0.14 ML, 0.21 ML, 1.75 ML, 3.5 ML, 4.2 ML, 5.6 ML, 7 ML; BEVACIZUMAB, SDPF - (0.08ML SYRINGE, 30G, 1/2\") 25MG/ML INJECTABLE 0.08 ML; BEVACIZUMAB, SDPF - (0.08ML SYRINGE, NO NEEDLE) 25MG/ML INJECTABLE 0.08 ML, 0.16 ML, 0.24 ML, 0.32 ML, 0.48 ML, 16 ML, 8 ML; BEVACIZUMAB, SDPF - (0.1", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1464-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62643", "recalling_firm": "Cadence Pharmaceuticals", "address_1": "12481 High Bluff Dr Ste 200", "address_2": "N/A", "postal_code": "92130-3583", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1432-2012", "product_description": "OFIRMEV (acetaminophen) injection, 1000 mg/100 mL (10 mg/mL), 24-count Single Use 100 mL Vials per carton, Rx only, Manufactured for: Cadence Pharmaceuticals, Inc., San Diego, CA  92130, NDC 43825-102-01, UPC 3 43825 10201 7.", "product_quantity": "1,098,912 vials", "reason_for_recall": "Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter.", "recall_initiation_date": "20120724", "center_classification_date": "20120731", "termination_date": "20131104", "report_date": "20120808", "code_info": "Lot #: V006015, V006023, V006031, V006056, V006064, V006080, V006106, V006114, V006130, V006148, V006155, Exp 07/12; V006171, V006189, V006197, V006205, V006213, V006221, V006254, V006262, V006270, V006296, V006304, V006312, V006320, V006338, V006346, V006353, V006361, V006379, V006387, V006395, Exp 08/12; V006403, V006429, V006437, V006445, V006460, V006494, V006510, V006528, V006536, V006544, Exp 09/12."}, {"status": "Terminated", "city": "Irvington", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62402", "recalling_firm": "Medtech Products, Inc.", "address_1": "90 North Broadway", "address_2": "N/A", "postal_code": "10533", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1673-2012", "product_description": "Little Remedies For Tummys, Stimulant Laxative (sennosides) Drops, 1 FL OZ (30 mL), Dist. by Medtech Products Inc., Irvington, NY 10533, UPC 7 56184 12071 2.", "product_quantity": "12,720 bottles", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product is being recalled because of sub-potency of the sennosides.", "recall_initiation_date": "20120620", "center_classification_date": "20120906", "termination_date": "20170411", "report_date": "20120912", "code_info": "Lot # 11338, Exp 04/13"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "110 units", "code_info": "Rx #'s:   0398154    0361427    0394539      0398379    0398383    0398654    0401481    0354901    0358554    0362399    0364565      0365677    0374214    0378140      0387717    0387828      0388410    0388613    0389582    0389605    0389831      0389995    0391836      0392132    0392791    0395761    0395780    0398565    0399139    0399236    0402039      0402348    0402913    0404655    0404956    0407300    0407826    0407886    0409193    0409392    0381541    0381541      0374200    0388333    0389328        0389995    0400261    0400734    0401275    0408300    0369037    0399507    0393432    0400721    0376498    0398517    0405296      0382422    0383030      0387924    0388078        0389173        0389292    0389398      0392540    0396157    0396195    0396743    0401143    0408802    0362184    0403309      0362184      0358883    0388846    0392210    0399742      0397435      0378334    0380750    0370502        0404839    0355136    0375023        0406832", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "QUADMIX 12MG/1MG/10MCG/150MCG/ML INJECTABLE\t10 ML;  QUADMIX 15MG/0.5MG/5MCG/100MCG/ML INJECTABLE\t10 ML;  QUADMIX 30MG/0.5MG/5MCG/100MCG/ML INJECTABLE\t10 ML;  \t  QUADMIX 30MG/1MG/10MCG/100MCG/ML INJECTABLE\t1 ML  \t  \t  \t  \t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 ML  \t30 ML  \t  \t5 ML;  \t  \t  \t  \t  \t  \t  \t  \t  \t  QUADMIX 30MG/1MG/20MCG/100MCG/ML INJECTABLE\t10 ML  \t  \t10 MLS  \t  \t5 ML;  \t  QUADMIX 30MG/1MG/40MCG/100MCG/ML INJECTABLE\t10 ML;  \t  QUADMIX 30MG/2MG/20MCG/100MCG/ML INJECTABLE\t10 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 ML  \t  \t  \t4 ML;  \t  QUADMIX 30MG/2MG/40MCG/100MCG/ML INJECTABLE\t10 ML  \t  \t  \t  \t  \t15 ML;  \t  QUADMIX 30MG/2MG/60MCG/100MCG/ML INJECTABLE\t5 ML;  QUADMIX 30MG/3MG/50MCG/100MCG/ML INJECTABLE\t10 ML  \t2.5 ML;  \t  \t  QUADMIX 30MG/4MG/60MCG/100MCG/ML INJECTABLE\t5 ML;  QUADMIX 30MG/6MG/60MCG/100MCG/ML INJECTABLE\t5 ML  (22 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1610-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #:  0388007", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYPERTONIC SOLUTION IN PRESERVED WATER 10% INJECTABLE 50 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1545-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077908"], "brand_name": ["PROPOFOL"], "generic_name": ["PROPOFOL"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-4699", "0409-6010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PROPOFOL"], "rxcui": ["1808217", "1808222", "1808224"], "spl_id": ["d55c0318-811d-4624-aa0c-456182f7b019"], "spl_set_id": ["28d7ba00-f824-4e55-139a-03f509c099db"], "package_ndc": ["0409-4699-50", "0409-4699-30", "0409-4699-53", "0409-4699-33", "0409-4699-54", "0409-4699-24", "0409-6010-02", "0409-6010-25"], "is_original_packager": [true], "nui": ["N0000175975", "N0000175681"], "pharm_class_pe": ["General Anesthesia [PE]"], "pharm_class_epc": ["General Anesthetic [EPC]"], "unii": ["YI7VU623SF"]}, "product_type": "Drugs", "event_id": "62999", "recalling_firm": "Hospira Inc.", "address_1": "375 N Field Dr", "address_2": "N/A", "postal_code": "60045-2513", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1672-2012", "product_description": "Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24", "product_quantity": "56,420 vials", "reason_for_recall": "Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.", "recall_initiation_date": "20120803", "center_classification_date": "20120830", "termination_date": "20140506", "report_date": "20120905", "code_info": "07-893-DJ, exp. 7/2013, 10-123-DJ, 10-125-DJ, exp. 10/2013"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "14 units", "code_info": "Rx #'s:  0397776    0377720    0388566    0388566    0379930      0396960    0402574    0379930    0391427    0391427    0391427    0391427    0408750", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FLUOROURACIL (5-FU) SOLUTION   5% OPHTHALMIC 100 ML;  FLUOROURACIL (5-FU) SOLUTION IN ARTIFICIAL TEARS 1% OPHTHALMIC 15 ML; FLUOROURACIL (5-FU) SOLUTION, P.F. 0.001% (10MCG/ML) OPHTHALMIC 20 ML, 30 ML; FLUOROURACIL P.F. 5% INJECTABLE 1000 ML,500 ML,\t600 ML; FLUOROURACIL SOLUTION PF 1% OPHTHALMIC 10 ML,  20 ML, 25 ML, 5 ML; FLUOROURACIL, P.F. 1% INJECTABLE 40 ML (12 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1520-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:   0398931,  0356347, 0398931", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "ZINC CHLORIDE 10MG/ML INJECTABLE\t30 ML  \t  \t60 ML  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1644-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078765"], "brand_name": ["FOSPHENYTOIN SODIUM"], "generic_name": ["FOSPHENYTOIN SODIUM"], "manufacturer_name": ["West-Ward Pharmaceuticals Corp"], "product_ndc": ["0143-9782", "0143-9788"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FOSPHENYTOIN SODIUM"], "rxcui": ["1670195", "1670200"], "spl_id": ["6b56fe59-9fb1-410b-b57c-7ada1662136a"], "spl_set_id": ["c92df63b-5140-4213-8d43-8327ff6230b7"], "package_ndc": ["0143-9788-01", "0143-9788-25", "0143-9782-01", "0143-9782-10", "0143-9703-10"], "is_original_packager": [true], "unii": ["7VLR55452Z"]}, "product_type": "Drugs", "event_id": "62627", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "All lots were distributed throughout the US.", "recall_number": "D-1438-2012", "product_description": "Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10 mL Single Dose Vial, packaged in 10-count x 10 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ  07724 USA under the labels a) NOVAPLUS (NDC 0143-9703-10), b) West-Ward (NDC 0143-9782-10).", "product_quantity": "a) 74,960 vials; b) 911,070 vials", "reason_for_recall": "Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.", "recall_initiation_date": "20120413", "center_classification_date": "20120802", "termination_date": "20150116", "report_date": "20120808", "code_info": "Lot #s: a) 112161.1, 112162.1, 112163.1, Exp 05/13; b) 102165.2, 102167.1, Exp 05/12; 102190.1, 102191.1, 102191.2, 102192.1, 102213.1, Exp 07/12; 102240.1, 102241.1, 10227.1, 102272.1, 102272.2, 102273.1, 102274.1, 102275.1, Exp 09/12; 102319.1, 102320.1, 102321.1, 102322.1, 102323.1, 102324.1, 102325.1, Exp 11/12; 102342.1, 102343.1, 102344.1, 102345.1, Exp 12/12; 112019.1, 112020.1, 112021.1, 112022.1, 112023.1, Exp 01/13; 112156.1, 112157.1, 112158.1, 112159.1, 112160.1, Exp 05/13; 112164.1, Exp 06/13; 112203.1, 112204.1, 112205.1, 112206.1, Exp 07/13; 112262.1, 112263.1, Exp 09/13; 112301.1, 112302.1, 112303.1, 112304.1, Exp 10/13; 112323.1, 112324.1, 112325.1, Exp 11/13"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "53 units", "code_info": "Rx #'s:    0385046    0406983    0367360          0384324    0406983    0397099    0398852    0398855    0398856    0405772    0406983    0390146      0398705    0398707    0398709    0398717    0398721    0398732    0377099    0377104    0384258    0384317    0390142      0390148      0390154    0390160    0390163    0390146    0404961    0369755    0377099    0377101    0377104      0380763    0384258    0384323    0384324    0390142    0390148    0391675    0400729    0405530    0377099    0377101    0377104    0380763", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "THERACYS, (BCG VACCINE) LIVE W/DILUENT** 81MG INJECTABLE\t1 VIAL  \t1 VIALS  \t12 VIAL  \t  \t  \t  \t12 VIALS  \t2 VIALS  \t3 VIALS  \t4 VIAL  \t  \t  \t4 VIALS  \t  \t5 VIAL  \t  \t  \t  \t  \t  \t  \t  \t5 VIALS  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 VIAL  \t  \t6 VIALS  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t8 VIALS  (13 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1624-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Erlanger", "address_1": "1820 Airport Exchange Blvd", "reason_for_recall": "Superpotent; benzocaine", "address_2": "", "product_quantity": "Lot #C2501: 18150 pieces of gum (1 per package); Lot #B2111: 18129 pieces of gum (1 per package)", "code_info": "Lot #s C2501 & B2111", "center_classification_date": "20120724", "distribution_pattern": "Nationwide", "state": "KY", "product_description": "Dent's Extra Strength Toothache Gum, (benzocaine 20%), Net Wt. .035 Oz.. (1 g) box, C.S. Dent & Co., Erlanger, KY", "report_date": "20120801", "classification": "Class II", "openfda": {}, "recalling_firm": "Grandpa Brands Co", "recall_number": "D-1425-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61838", "termination_date": "20130301", "more_code_info": "", "recall_initiation_date": "20120509", "postal_code": "41018-3192", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA072204"], "brand_name": ["LOXAPINE"], "generic_name": ["LOXAPINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0369", "0591-0370", "0591-0371", "0591-0372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LOXAPINE SUCCINATE"], "rxcui": ["311385", "311386", "314075", "314078"], "spl_id": ["cae2db34-6be2-45cf-b9b5-9b929650eb4f"], "spl_set_id": ["a6107bb1-3e23-4c5d-bbf4-5e29deff6728"], "package_ndc": ["0591-0369-01", "0591-0370-01", "0591-0371-01", "0591-0372-01"], "is_original_packager": [true], "upc": ["0305910369019", "0305910370015", "0305910372019"], "unii": ["X59SG0MRYU"]}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1401-2012", "product_description": "Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880  NDC #  0591-0371-01", "product_quantity": "21,572 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot #s: 101696A, 110829A, 123685A, 123687A"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:  0405376    0386923          0397004      0397004", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DMSO/HEPARIN 50%/20,000U/25ML SOLUTION 100 ML, 25 ML; DMSO/HEPARIN 50%/5000U/50ML SOLUTION 300 ML, 400 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1506-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62350", "recalling_firm": "sanofi-aventis US, Inc.", "address_1": "Route 202-206", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1408-2012", "product_description": "Eloxatin (OXALIplatin injection) 5 mg/mL injection, 100 mg,  Rx only, Mfd. for: sanofi aventis US LLC Bridgewater, NJ 08807, NDC 0024-0591-20", "product_quantity": "387,738 vials", "reason_for_recall": "CGMP Deviations:  Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues in Good Manufacturing Practices.", "recall_initiation_date": "20120206", "center_classification_date": "20120705", "termination_date": "20131203", "report_date": "20120711", "code_info": "Lot number and expiration dates    Eloxatin\u00bf (OXALIplatin injection) 100mg vial AD21 02/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial AD22 02/ 2012  Eloxatin\u00bf (OXALIplatin injection) 100mg vial AE24 02/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial AE25 02/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial AF55 02/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial AE26 03/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial AF03 03/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial AF04 03/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial AF21 03/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial BL19B 03/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial CB11B 04/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial CB102B 04/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial CB12B 04/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial CA01B 04/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial BH07 06/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial BH08 06/ 2012  Eloxatin\u00bf (OXALIplatin injection) 100mg vial BH09 06/ 2012   Eloxatin\u00bf (OXALIplatin injection) 100mg vial CC109B 01/ 2014"}, {"country": "United States", "city": "Shenandoah", "address_1": "604 W Thomas Ave", "reason_for_recall": "Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.", "address_2": "Po Box 130", "product_quantity": "19,166 bottles", "code_info": "Lot 1087589", "center_classification_date": "20120622", "distribution_pattern": "Nationwide and PR.", "state": "IA", "product_description": "Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. bottles, RX, NDC 0456-1321-01.  Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Lloyd Inc", "recall_number": "D-1393-2012", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "61094", "termination_date": "20130730", "more_code_info": "", "recall_initiation_date": "20120203", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "92 units", "code_info": "Rx #'s:N0396046  N0397450  N0404861  N0404320  N0389241  N0398238  N0408869  N0396836  N0390297  N0393345  N0393647  N0395395  N0397377  N0400800  N0403100  N0405536  N0408890  N0390024  N0391848  N0398239  N0403727  N0386864  N0388540  N0391192  N0391588  N0391831  N0391832  N0395396  N0396449  N0403824  N0403830  N0405260  N0405432  N0406253  N0407952  N0408884  N0393648  N0408194  N0394358  N0397366  N0397367  N0398708  N0398710  N0399636  N0400170  N0403098  N0405257  N0391608  N0401173  N0403253  N0405115  N0406436  N0390298  N0395170  N0407252  N0407520  N0392176  N0399300  N0406567  N0407428  N0387601  N0401757  N0388225  N0388588  N0392887  N0395240  N0398236  N0400870  N0404729  N0408213  N0399681  N0394427  N0388559  N0402004  N0386844  N0406159  N0390186  N0396640  N0404315  N0388587  N0402386  N0409165  N0389663  N0392048  N0387598  N0395522  N0396441  N0403779  N0405538  N0406915  N0399871  N0407182", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "MORPHINE SULFATE 2MG/ML INJECTABLE\t10 ML;  MORPHINE SULFATE MDV 10MG/ML INJECTABLE\t10 ML  \t25 ML  \t30 ML;  MORPHINE SULFATE, P.F. (0.9%  SODIUM CHLORIDE) 50MG/ML INTRATHECAL\t18 ML  \t  \t  \t40 ML;  MORPHINE SULFATE, P.F. (0.9% SODIUM CHLORIDE) 15MG/ML INTRATHECAL\t40 ML;  \t  \t  \t  \t  \t  \t  \t  \t  MORPHINE SULFATE, P.F. (0.9% SODIUM CHLORIDE) 20MG/ML INTRATHECAL\t18 ML  \t  \t  \t  \t40 ML;  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  MORPHINE SULFATE, P.F. (0.9% SODIUM CHLORIDE) 25MG/ML INTRATHECAL\t20 ML  \t  \t40 ML;  \t  \t  \t  \t  \t  \t  \t  MORPHINE SULFATE, P.F. (0.9% SODIUM CHLORIDE) 38MG/ML INTRATHECAL\t50 ML;  MORPHINE SULFATE, P.F. (0.9% SODIUM CHLORIDE) 5MG/ML INTRATHECAL\t40 ML;  \t  \t  \t  \t  MORPHINE SULFATE, P.F. 10MG/ML INTRATHECAL\t40 ML;  \t  \t  \t  MORPHINE SULFATE, P.F. 11.5MG/ML INTRATHECAL\t35 ML;  \t  \t  MORPHINE SULFATE, P.F. 1MG/ML INJECTABLE\t250 ML;  MORPHINE SULFATE, P.F. 25MG/ML INTRATHECAL\t30 ML;  \t  MORPHINE SULFATE, P.F. 30MG/ML INTRATHECAL\t18 ML;  \t  \t  \t  \t  \t  \t  \t  MORPHINE SULFATE, P.F. 33MG/ML INTRATHECAL\t30 ML;  MORPHINE SULFATE, P.F. 35MG/ML INTRATHECAL\t35 ML;  MORPHINE SULFATE, P.F. 40MG/ML INTRATHECAL\t18 ML  \t  \t20 ML  \t  \t35 ML;  \t  \t  MORPHINE SULFATE, P.F. 42MG/ML INTRATHECAL\t35 ML;  \t  \t  MORPHINE SULFATE, P.F. 50MG/ML INTRATHECAL\t18 ML  \t  \t40 ML;  \t  \t  \t  \t  MORPHINE SULFATE, P.F. 5MG/ML INTRATHECAL\t40 ML;  MORPHINE SULFATE/BACLOFEN P.F. 25MG/1500MCG/ML INTRATHECAL\t18 ML  (28 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1585-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:  0393869    0393871    0356246    0357036", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DOXORUBICIN HCL, LYOPHILIZED 10MG VIAL 2 VIAL; DOXORUBICIN HCL, LYOPHILIZED 50MG VIAL 1 VIAL, 10 VIAL, 5 VIAL (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1509-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:  0404389    0405327    0369106    0398391    0389137        0399520", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PROGESTERONE AQUEOUS 2MG/ML INJECTABLE\t3 ML;  PROGESTERONE IN COTTONSEED OIL 50MG/ML INJECTABLE\t30 ML;  PROGESTERONE IN SESAME OIL 100MG/ML INJECTABLE\t200 ML;  PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE\t1000 ML;  PROGESTERONE IN SESAME OIL 50MG/ML INJECTABLE\t10 MLS  \t  \t  \t30 ML  (6 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1608-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076392"], "brand_name": ["MEFLOQUINE HYDROCHLORIDE"], "generic_name": ["MEFLOQUINE HYDROCHLORIDE"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0171"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MEFLOQUINE HYDROCHLORIDE"], "rxcui": ["835913"], "spl_id": ["33a105c5-0e51-4759-857b-6ca8dfae1d13"], "spl_set_id": ["09716a24-d7da-42b2-af29-c03a1b6670bd"], "package_ndc": ["0555-0171-88", "0555-0171-78"], "is_original_packager": [true], "unii": ["5Y9L3636O3"]}, "product_type": "Drugs", "event_id": "61664", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1396-2012", "product_description": "Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78", "product_quantity": "4188 cartons (5 X 5 blisterpacks)", "reason_for_recall": "Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.", "recall_initiation_date": "20120402", "center_classification_date": "20120626", "termination_date": "20130322", "report_date": "20120704", "code_info": "Lot # 34000741A;  Expiration date: 7/2013", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:N0397554  N0402371", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUPIVACAINE/CLONIDINE/MORPHINE, P.F. 20MG/400MCG/20MG/ML INTRATHECAL 20 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1472-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ronkonkoma", "address_1": "2 Fleetwood Ct", "reason_for_recall": "Microbial contamination of Non Sterile Product; contamination with Burkholderia cepacia (manufacturer)", "address_2": "", "product_quantity": "", "code_info": "Antiseptic wipes shipped since July 02, 2009. Lots:   JT34808, JT08209,  JT15209,  JT32809,  JT00610,  JT27610,  JT05311,  JT18211,  JT22711-1, JT26411,  JT01012, JT00610, JT14511, JT22011, JT30711", "center_classification_date": "20120917", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "Dukal Corporation BZK Swab, First Aid Antiseptic, (Benzalkonium Chloride), 0.133% w/v, Item 854-1000 contains 1000 individually packaged swabs per box. Item 854 contains 200 individually packaged swabs per box. Packaging labeled with Dukal Corporation, Hauppauge, NY 11788 --- NDC 65517-00031", "report_date": "20120926", "classification": "Class II", "openfda": {}, "recalling_firm": "Dukal Corp.", "recall_number": "D-1676-2012", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "62320", "termination_date": "20130621", "more_code_info": "", "recall_initiation_date": "20120614", "postal_code": "11779-6907", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx #'s:   0392592    0392592    0392592      0392592    0391541    0391541", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LEVOFLOXACIN, P.F. (PREMIXED SOLUTION) 5MG/ML  INJECTABLE\t1200 ML  \t500 ML  \t700 ML  \t  \t800 ML  LEVOFLOXACIN, P.F. 25MG/ML(500MG/20ML) INJECTABLE\t300 ML  \t500 ML  (6 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1556-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0405733    0353173    0349837    0392673", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DMPS 250MG/10ML INJECTABLE 20 ML, 30 ML; DMPS 50MG/ML (500MG/10ML) INJECTABLE 10 ML, 5 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1504-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "21 units", "code_info": "Rx #'s:  0406446,  0404313,  0381309,  0390603,  0350228,  0389240,  0365111,  0383582,  0391840,  0399130,  0372385,  0387886,  0406914", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BACLOFEN, P.F. (WITH 0.9% P.F. NORMAL SALINE) 2,000MCG/ML (2MG/ML) INTRATHECAL 40 ML; BACLOFEN, P.F. (WITH 0.9% P.F. NORMAL SALINE) 600MCG/ML  INTRATHECAL 40 ML; BACLOFEN, P.F. 1,000MCG/ML (1MG/ML) INTRATHECAL 20 ML, 40 ML; BACLOFEN, P.F. 500MCG/ML (0.5MG/ML) INTRATHECAL 40 ML; BACLOFEN, PRESERVATIVE FREE 3000MCG/ML INJECTABLE 40 ML; BACLOFEN, PRESERVATIVE FREE 3300MCG/ML(3.3MG/ML) INTRATHECAL 20 ML; BACLOFEN, PRESERVATIVE FREE 5000MCG/ML(5MG/ML) INTRATHECAL 40 ML (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1459-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Tulsa", "address_1": "12515 E 55th St Ste 100", "reason_for_recall": "Impurities/Degradation Products; Product is being recalled due to the potential of not meeting the Impurity C specification through the product shelf life", "address_2": "", "product_quantity": "60 bottles", "code_info": "Lot # 5ASX, Exp 10/31/2011; 5O37; 5QSQ; 5T6J; 5U7Z; 5WIC; 5XDS; 5ZHY;  601J; 63MJ; 64O0, Exp. 02/28/2012.", "center_classification_date": "20120622", "distribution_pattern": "GA, PA", "state": "OK", "product_description": "Methylprednisolone Tablets, USP, 4 mg, 20 tablets per bottle, Repacked & Distributed by: Physicians Total Care Inc., Tulsa, OK 74146, NDC # 54868-2913-03", "report_date": "20120704", "classification": "Class II", "openfda": {}, "recalling_firm": "Physicians Total Care, Inc.", "recall_number": "D-1391-2012", "initial_firm_notification": "FAX", "product_type": "Drugs", "event_id": "62122", "termination_date": "20130222", "more_code_info": "", "recall_initiation_date": "20110318", "postal_code": "74146-6234", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0398938", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "RUBIDIUM 200MCG/ML INJECTABLE\t30 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1614-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "16 units", "code_info": "Rx #'s:   0392878,  0398614,  0394932,  0394932,  0387461,  0352013,  0391247,  0391792,  0399973,  0401614,  0402893,  0392721,  0392721,  0382234", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ALTEPLASE, SDPF - (0.05ML SYRINGE, 30G, 1/2\") 1000MCG/ML INJECTABLE 0.05 ML; ALTEPLASE, SDPF - (0.15ML LL SYRINGE, NO NEEDLE) 100MCG/ML (10MCG/0.1ML) INJECTA 0.15 ML, 0.3 ML; ALTEPLASE, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 1000MCG/ML INJECTABLE 0.1 ML, 0.2 ML, 0.3 ML;  ALTEPLASE, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 100MCG/ML (10MCG/0.1ML) INJECTABLE 0.1 ML, 0.3 ML; ALTEPLASE, SDPF - (0.1ML SYRINGE, 30G, 1/2\") 250MCG/ML (25MCG/0.1ML) INJECTABLE 0.1 ML (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1453-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx #'s:N0406290, N0387600, N0390988, N0393344, N0396645, N0400013, N0403729, N0406665, N0410203, N0393490", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BACLOFEN/BUPIVACAINE/CLONIDINE/MORPHINE, P.F. 1000MCG/7.5MG/1000MCG/50MG/ML INTR 40 ML; BACLOFEN/BUPIVACAINE/CLONIDINE/MORPHINE, P.F. 50MCG/2MG/200MCG/50MG/ML INTRATHEC 18 ML; BACLOFEN/CLONIDINE/BUPIVACAINE/MORPHINE, P.F. 500MCG/1/7.5/50MG/ML INTRATHECAL 40 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1460-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "22 units", "code_info": "Rx #'s:   0391307      0387323    0394852    0390852    0391092    0391452    0391582    0387323    0387323    0402850      0409602    0388849    0395801    0401312    0362629      0393748      0405277    0391772", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METHIONINE / INOSITOL / CHOLINE CHLORIDE 25MG/75MG/75MG/ML INJECTABLE\t30 ML;  \t  METHIONINE/INOSITOL/CHOLINE CHLORIDE  0.8%/1.6%/1.6% INJECTABLE\t180 ML  \t  \t24 ML  \t  \t  \t  \t240 ML  \t270 ML  \t30 ML  \t  \t  \t90 ML  \t  METHIONINE/INOSITOL/CHOLINE CHLORIDE  25MG/50MG/50MG/ML INJECTABLE\t120 ML  \t300 ML  \t  \t  \t  \t  METHIONINE/INOSITOL/CHOLINE CHLORIDE/B1/B2 0.8%/1.6%/1.6% INJECTABLE\t60 ML  (10 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1571-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0392313", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYCLOPENT/LIDOCAINE/PHENYLEPHRINE/TROPICAMIDE 0.5%/0.5%/0.625%/0.25% OPHTHALMIC 20 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1491-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:    0401630", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "PANTOTHENIC ACID 1MG/ML INJECTABLE\t30 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1592-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "3 units", "code_info": "Rx #'s:    0398569    0399778    0398076", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "RANITIDINE 25MG/ML INJECTABLE\t200 ML  \t480 ML  \t800 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1612-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:  0383013, 0383013", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BORON 2MG/ML INJECTABLE 40 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1467-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "72 units", "code_info": "Rx #'s:  0389464    0398833    0399748    0402917    0402926    0405892    0404079    0404086    0392875    0398067    0403137    0403795    0404506    0408694    0404895    0387492    0389813    0390461    0391264    0391818    0391961    0392952    0393766    0395543    0396232    0396925    0397181    0397313    0397959    0399219    0400227    0400749    0400845    0401497    0401998    0402465    0402997    0403162    0405298    0405330    0405341    0406903    0407419    0408021    0409309    0409791    0402406    0402414    0389982    0389976    0407175    0386101    0391782    0394584    0399576    0403154    0403358    0404795    0406532    0409701    0410127    0400234    0389894      0369509    0407537    0387936    0388504      0401671    0391774    0395019", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ESTRADIOL 25MG PELLETS 1 PELLET, 15 PEL, 15 PELLET, 2 PELLET, 2 TAB, 3 PELLET, 4 PELLET, 6 PELL, 6 PELLET; ESTRADIOL 50MG PELLETS 1 PELELT, 1 PELLET, 4 PELLET, 6 PELLET; ESTRADIOL CYPIONATE 5MG/ML INJECTABLE 5 ML; ESTRADIOL VALERATE IN COTTONSEED OIL 40 MG/ML INJECTABLE 10 ML; ESTRADIOL VALERATE IN SESAME OIL 40 MG/ML INJECTABLE 10 ML (16 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1515-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "9 units", "code_info": "Rx #'s:  0393533    0387959        0366146    0395006    0401280      0408662", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DMSO/VITAMIN C/GLUTATHIONE SOLUTION 6.25%/1.25%/1.25% OPHTHALMIC 10 ML, 15 ML, 5 ML (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1508-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:  0390774, 0392517", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "BUDESONIDE (P.F) NASAL IRRIGATION 0.5MG/500ML  SOLUTION\t1000 ML; BUDESONIDE (P.F) NASAL IRRIGATION 0.6MG/50ML  SOLUTION 1500 ML (2 DIFFERENT UNITS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1469-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0410218", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "POVIDONE-IODINE/LIDOCAINE/TETRACAINE 4.6%/4%/0.5% OPHTHALMIC\t30 ML  (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1605-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "86 units", "code_info": "Rx #'s:    0387434      0387442    0373259    0379220        0379925    0381812      0382155    0389481    0391043    0391912    0392598    0393303    0397302    0368903    0385563    0377621    0389560    0376591    0387169      0375580    0388039    0381499    0387434    0387442    0368903              0398369              0385601      0381154    0382450    0395591    0399380    0400168    0401501    0375406        0388039    0370251      0379203    0380414    0373568    0373668    0379036    0376722    0380943    0381499    0384292    0388741    0395917    0373742    0387702      0389521    0373742    0401945    0409583    0404840    0407920    0407921    0407922    0407923    0407925    0407926    0407928    0407931    0407933    0407935    0403019    0406664", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CYANOCOBALAMIN (VIT B12 ) 1,000MCG/ML INJECTABLE 1 ML, 10 ML, 100 ML, 12 ML, 120 ML, 15 ML, 150 ML,\t180 ML, 2 ML, 200 ML, 3 ML, 30 ML, 300 ML, 32 ML, 4 ML, 5 ML,\t6 ML, 60 ML, 90 ML; CYANOCOBALAMIN **1000MCG/ML INJECTABLE  1000MCG/ML INJECTABLE\t30 ML; CYANOCOBALAMIN***  (25X10ML VIAL) 1000MCG/ML INJECTABLE 10 ML, 20 MLS, 40 ML; CYANOCOBALMIN ***(VIT B-12) 25X1ML 1000MCG/ML INJECTABLE 50 MLS (24 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1488-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "19 units", "code_info": "Rx #'s:  0397570    0397570    0397570    0397570    0397570    0373846    0373846    0373846      0373846    0373846    0373846    0373846    0373846    0373846    0373846    0373846    0373846    0373846", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "RANIBIZUMAB, SDPF - (0.05ML SYRINGE, 31G, 5/16\") 10MG/ML INJECTABLE\t1 ML  \t1.25 ML  \t1.75 ML  \t2.3 ML  \t2.35 ML  \t20 ML  \t20.15 ML  \t20.45 ML  \t  \t20.6 ML  \t20.9 ML  \t21.05 ML  \t21.2 ML  \t21.25 ML  \t21.45 ML  \t21.6 ML  \t21.7 ML  \t24.4 ML  \t28.1 ML  (18 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1611-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx #'s:  0389839            0389283        0404785    0390956", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "TRIMIX/LIDOCAINE              11.8MG/0.39MG/10.6MCG/1.7MG/ML  INJECTABLE\t30 ML;  \t  \t  \t  \t  TRIMIX/LIDOCAINE              13.6MG/0.45MG/38.2MCG/7.3MG/ML  INJECTABLE\t10 ML;  \t  \t  TRIMIX/LIDOCAINE     12MG/1MG/5MCG/1%/ML INJECTABLE\t10 MLS;  TRIMIX/LIDOCAINE 17.65MG/0.59MG/5.9MCG/2% INJECTABLE\t10 ML  (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1630-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:   0401261    0371940      0396624    0401261    0402167    0387248", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYDROGEN PEROXIDE PF 3% INJECTABLE\t150 ML, 200 ML, 50 ML, 60 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1539-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0389733      0398961        0398282", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYDROCHLORIC ACID INJECTION 2MG/ML INJECTABLE 400 ML, 60 ML (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1538-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "20 units", "code_info": "Rx #'s:  0370177        0370177    0370177      0387585      0370177      0387584        0387584    0387584          0387584    0370176      0370176", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE HCL/BUPIVACAINE HCL PF 1%/0.375% OPHTHALMIC\t30 ML  \t  \t  \t48 ML  \t60 ML  \t  \t  \t  \t90 ML;  \t  LIDOCAINE HCL/BUPIVACAINE/HYALURONIDASE PF 0.83%/0.312%/16.67U/ML OPHTHALMIC\t30 ML  \t  \t  \t48 ML  \t60 ML  \t  \t  \t  \t90 ML;    LIDOCAINE/BUPIVACAINE/HYALURONIDASE PF 1.776%/0.335%/22.22UNITS/ML OPHTHALMIC\t30 ML  \t  \t60 ML  \t  (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1559-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:  0384580    0384580      0384580", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "THIAMINE HCL 100MG/ML INJECTABLE\t300 ML  \t360 ML  \t  \t450 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1625-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #'s:  0398994    0387653", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "OXYTOCIN 10UNITS/ML INJECTABLE\t25 ML;  OXYTOCIN**(25X1ML) 10U/ML INJECTABLE\t25 MLS  (2 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1590-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "8 units", "code_info": "Rx #'s:   0398900        0399056    0404399    0391716    0391716    0391716", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METHYLPREDNISOLONE ACETATE 100MG/ML INJECTABLE\t50 ML;  \t  \t  \t  METHYLPREDNISOLONE ACETATE 80MG/ML INJECTABLE\t1 ML  \t30 ML  \t6 ML  \t60 ML  (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1575-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hobart", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "61967", "recalling_firm": "Mallinckrodt Inc.", "address_1": "172 Railroad Avenue", "address_2": "N/A", "postal_code": "13788-0416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1430-2012", "product_description": "Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5 mg/500 mg per 15 mL, 16 fl oz (473 mL) bottle, Rx only, Mallinckrodt Inc., Hazelwood, MO 63042 USA, NDC 0406-0375-16, UPC 3 0406-0375-16 1.", "product_quantity": "41,100 bottles", "reason_for_recall": "Subpotent (Multiple Ingredient) Drug: Low out of specification assay results for the hydrocodone bitartrate ingredient was found.", "recall_initiation_date": "20120525", "center_classification_date": "20120731", "termination_date": "20150417", "report_date": "20120808", "code_info": "Lot #: 0375T79384, Exp 05/13; 0375T81348,  Exp 09/13; 0375U82277, Exp 01/14"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "5 units", "code_info": "Rx #:  0370657    0391175    0397241      0397241", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEXPANTHENOL 250MG/ML INJECTABLE 100 ML, 120 ML, 360 ML, 450 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1499-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "9 units", "code_info": "Rx #'s:C0388707  C0393621  C0397891  C0397894  C0397896  C0397905  C0404812  C0405366  C0407575", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DEPO-TESTOSTERONE, MDV, 10ML** 200MG/ML INJECTABLE 10 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1496-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "11 units", "code_info": "Rx #'s:   0370173      0370173    0370173    0370173    0371532      0371532    0371532      0371532", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE/EPINEPHRINE/BUPIVACAINE, PF 1%/0.00025%/0.375% OPHTHALMIC\t30 ML  \t  \t48 ML  \t60 ML  \t90 ML;  LIDOCAINE/EPINEPHRINE/BUPIVACAINE, PF 1%/0.0005%/0.25% OPHTHALMIC\t30 ML  \t  \t48 ML  \t60 ML  \t  \t90 ML  (8 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1561-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "21 units", "code_info": "Rx #'s:   0392865    0396841    0392865    0389079      0401264    0401264    0389079    0351538    0379811    0398960        0396622    0367514", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CALCIUM CHLORIDE DIHYDRATE, P.F. 100MG/ML (10%) INJECTABLE 200 ML, 240 ML, 500 ML; CALCIUM EDTA 150MG/ML INJECTABLE 1000 ML, 800 ML, 900 ML; CALCIUM EDTA 300MG/ML INJECTABLE 400 ML, 500 ML; CALCIUM GLUCONATE OPHTHALMIC IN ARTIFICIAL TEARS 1%  OPHTHALMIC 500 ML (9 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1480-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "12 units", "code_info": "Rx #'s:  0387947    0391167      0394583    0394583      0394579    0390379          0390379", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HEPARIN LOCK SODIUM*** (25X1ML) 100U/ML INJECTABLE 50 ML;  HEPARIN LOCK SODIUM*** (25X5ML) 100U/ML INJECTABLE 125 MLS; HEPARIN SODIUM (25X30ML)** 1000U/ML(1MU/ML) INJECTABLE 120 ML, 60 ML, 90 ML; HEPARIN SODIUM **25X1ML 1000U/ML(1MU/ML INJECTABLE 25 ML, 50 ML (7 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1531-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62574", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1439-2012", "product_description": "Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL, 10mL bottle, For Topical Application in the Eye, Sterile Ophthalmic Solution, Rx Only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9", "product_quantity": "119,794 Bottles", "reason_for_recall": "Presence of Particulate Matter:  Lots identified in this recall notification may contain small particulates.", "recall_initiation_date": "20120430", "center_classification_date": "20120802", "termination_date": "20130919", "report_date": "20120808", "code_info": "Lot #s: JN1060, JN1061, JN1062, Exp 06/12"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA072168"], "brand_name": ["CYTARABINE"], "generic_name": ["CYTARABINE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-303"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CYTARABINE"], "rxcui": ["240416"], "spl_id": ["304df26a-131c-4ce1-999a-f13ade44373e"], "spl_set_id": ["681b5dc4-4fcf-4fab-ad78-02cb9a4a5dd0"], "package_ndc": ["61703-303-46"], "is_original_packager": [true], "nui": ["N0000000233", "N0000175595"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "unii": ["04079A1RDZ"]}, "product_type": "Drugs", "event_id": "62459", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, including Puerto Rico and Guam.    Product was also distributed internationally to Australia, Belgium, Canada, France, Germany, Korea, Malaysia, New Zealand, Norway, Pakistan, Philippines, Portugal, Singapore, Sweden, Thailand and  Vietnam", "recall_number": "D-1680-2012", "product_description": "Cytarabine Injection, 20 mg/mL, 50 mL Single Dose Vial, Rx only,  antineoplastic/cytotoxic agent; Manufactured for Hospira, Inc., Lake Forest, IL 60045, Product of Australia; NDC 61703-303-46", "product_quantity": "210 vials", "reason_for_recall": "The affected lots of Carboplatin Injection, Cytarabine  Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.", "recall_initiation_date": "20120627", "center_classification_date": "20120919", "termination_date": "20161215", "report_date": "20120926", "code_info": "lot numbers Y131994AA, exp AUG 2013; Y141994AA, exp SEP 2013; Y151994AA, exp SEP 2013; Y161994AA, exp NOV 2013; Y171994AA, exp NOV 2013 and Y181994AA, exp NOV 2013", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:  0389781", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HUMULIN-R INSULIN, 10ML VIAL** 100U/ML INJECTABLE\t10 MLS (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1532-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "107 units", "code_info": "Rx #'s:   0368127    0368127        0396422    0394589    0389031    0397908    0405717    0377092    0395743    0399094    0364766    0377092    0383467    0395743    0399094    0385418    0377092    0391512    0397919    0409221    0395743      0383467    0410209    0353611    0397908    0409800    0372333    0381650    0388770    0357605    0399192    0357605    0357605    0399192        0357605    0370950    0384873    0389326    0357967    0399100      0356533    0361811    0368706    0392087    0401999    0402000    0402006    0405708    0408219    0361811    0368706      0371146    0379509    0380104    0384873          0393576    0403473    0405271    0405527    0371848      0388317    0399025    0408772    0398966      0398276    0352407    0371146      0375451      0377804        0383961    0384873      0388317    0391725    0392087      0393569    0396968    0371146      0375451    0368706    0399665    0401355    0402666      0407936    0362282    0388317      0368311", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DMSO / BUPIVACAINE HCL 50%/0.5% INJECTABLE 100 ML, 50 ML; DMSO 100% INJECTABLE 100 ML; DMSO FORTIFIED IRRIGATION - W/O HEPARIN  SOLUTION\t350 ML; DMSO FORTIFIED IRRIGATION 50%/0.01%/44%/1% SOLUTION\t1000 ML, 1200 ML, 150 ML, 200 ML, 250 ML, 300 ML, 400 ML, 500 ML, 600 ML; DMSO FORTIFIED IRRIGATION 50%/44%/1% SOLUTION\t50 ML;  DMSO FORTIFIED IRRIGATION W/LIDOCAINE 50%/0.01%/44%/1%/1% SOLUTION\t250 ML; DMSO IRRIGATION - NACHO3 50% SOLUTION 100 ML, 300 ML, 400 ML, 500 ML, 600 ML; DMSO W/LIDOCAINE 50%/0.5% SOLUTION 100 ML, 1200 ML, 150 ML, 200 ML,\t250 ML, 2500 ML, 30 ML, 300 ML, 400 ML, 50 ML, 500 ML, 600 ML (32 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1505-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "193 units", "code_info": "Rx #'s:  0389332    0388230      0362007    0362537    0369266    0369759    0376765      0376766    0378972    0381347    0381668    0383006    0384070    0387408    0387842    0387873    0388522    0388825    0389034    0389038    0389347    0389746    0389824    0389913    0390210    0390265    0390267    0390404    0390481    0391083    0391374    0391789    0392302    0392329    0393161    0393238    0393733    0393734    0394038    0396204    0396253    0396951    0397068    0397814    0397816    0398167    0398775    0398809    0399039      0399168      0400419      0401454    0401456    0401717    0402440    0402443    0403637    0377693    0382907    0389892    0390269    0393418    0397085    0397984    0398761    0401192    0401453    0401702    0402969    0403042    0353856    0380968        0389852    0396383    0396985      0397369    0405720    0409461    0400111    0392017    0405577    0405591    0407190    0390553            0410265    0393727    0394656    0399169    0403590      0392209    0392212    0392214    0392215    0392217    0394902    0395795    0395799    0395800    0395880      0395884      0395885      0398821    0399797    0403933    0405574    0405578    0405607    0405608    0406394    0410495    0394528    0395347    0392045    0393681    0393682    0394381    0396742    0396763    0401783    0401785    0405205    0404805    0397298      0398209    0401610    0404696    0406424    0408386    0408794    0409008    0409330    0409500    0409511    0410093    0410179    0410202    0410327    0394569    0397231    0400352    0400360    0410043    0410045    0410046    0394569    0394569    0407106    0407854    0409176    0408788    0394569      0405634    0394765    0405634    0392318    0394569    0373437    0381856    0387413    0397985    0398350    0394512    0401471    0404558    0393614    0397800    0387413    0406999    0397800    0397822    0388830      0380110    0407385    0380110", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "CHORIONIC GONADOTROPIN (STANDARD) - 21 DAY 200 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN (STANDARD) - 45 DAY 200 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN (STANDARD)-21 DAY 125 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN (STANDARD)-45 DAY 125 UNIT VIALS KIT 1 KIT; CHORIONIC GONADOTROPIN + B12, LYOPHILIZED  4,000 UNIT/40MCG/ML KIT 1 KIT, 2 KIT, 3 KIT; CHORIONIC GONADOTROPIN + B12, LYOPHILIZED (HCG) 4,000 UNIT VIAL INJECTABLE 1 VIAL, 12 VIALS;  CHORIONIC GONADOTROPIN KIT 5,000 UNIT VIAL INJECTABLE 1 KIT; CHORIONIC GONADOTROPIN** KIT 10,000 UNIT VIAL INJECTABLE 1 KIT; CHORIONIC GONADOTROPIN, HUMAN - MINI 250 UNITS TROCHE 30 TROCHE, 45 TROCHE, 50 TROCHE, 60 TROCHE, 80 TROCHE; CHORIONIC GONADOTROPIN, LYOPHILIZED   (HCG) 1,000 UNIT VIAL INJECTABLE 30 VIAL; CHORIONIC GONADOTROPIN, LYOPHILIZED   (HCG) 5,000 UNIT VIAL INJECTABLE 1 VIAL, 10 VIAL, 14 VIAL, 15 VIAL, 2 VIAL, 2 VIALS, 20 VIAL, 3 VIAL, 5 VIAL, 6 VIAL; CHORIONIC GONADOTROPIN, LYOPHILIZED  (HCG) 125 UNIT VIAL (UNIT DOSE) INJECTABLE 10 VIAL, 14 VIAL, 15 VIAL,\t2 VIAL, 24 VIAL, 28 VIAL, 28 VIALS, 7 VIAL,\t7 VIALS; CHORIONIC GONADOTROPIN, LYOPHILIZED (HCG) 2,500 UNIT VIAL INJECTABLE 5 VIAL; CHORIONIC GONADOTROPIN, LYOPHILIZED (HCG) 200 UNIT VIAL (UNIT DOSE) INJECTABLE 22 VIAL, 25 VIAL, 8 VIAL (40 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1483-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Broomfield", "address_1": "2555 W Midway Blvd", "reason_for_recall": "Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.", "address_2": "", "product_quantity": "43,060 x 90 count bottles", "code_info": "Lot numbers: BJ3338; BJ3339; BJ 3340; BJ3341; BJ3342; BJ6282; BJ7192; BM8498; BJ7202; BJ7203, Exp 12/12", "center_classification_date": "20120919", "distribution_pattern": "Nationwide", "state": "CO", "product_description": "Pramipexole Dihydrochloride Tablets, 0.25 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-  5249-92,", "report_date": "20120926", "classification": "Class III", "openfda": {}, "recalling_firm": "Sandoz Incorporated", "recall_number": "D-1677-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63160", "termination_date": "20130410", "more_code_info": "", "recall_initiation_date": "20120912", "postal_code": "80020-1632", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M027"], "brand_name": ["MIDOL COMPLETE"], "generic_name": ["ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE"], "manufacturer_name": ["Bayer HealthCare LLC."], "product_ndc": ["0280-8005"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "CAFFEINE", "PYRILAMINE MALEATE"], "rxcui": ["1597298"], "spl_id": ["32714ca6-82e9-932c-e063-6394a90ae97d"], "spl_set_id": ["ce9e6acb-a38b-4c9b-a7e8-3e1c2a49a324"], "package_ndc": ["0280-8005-16", "0280-8005-24", "0280-8005-40", "0280-8005-01", "0280-8005-02", "0280-8005-04", "0280-8005-25"], "is_original_packager": [true], "upc": ["0312843555198"], "nui": ["N0000175739", "N0000175729", "N0000175790", "M0023046"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["362O9ITL9D", "3G6A5W338E", "R35D29L3ZA"]}, "product_type": "Drugs", "event_id": "61948", "recalling_firm": "Bayer Healthcare, LLC", "address_1": "36 Columbia Rd", "address_2": "", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 93 retail accounts/customers.", "recall_number": "D-1424-2012", "product_description": "Midol Complete, Acetaminophen, Caffeine, Pyrilamine Maleate, Caplets, OTC, a) 16 ct. blister (NDC 0280-8005-16), b)24 ct. blister, Distributed by Bayer Health Care, Morristown, NJ 07962 (NDC 0280-8005-25)", "product_quantity": "48,528 cartons", "reason_for_recall": "Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.", "recall_initiation_date": "20120426", "center_classification_date": "20120719", "termination_date": "20140327", "report_date": "20120725", "code_info": "NAA055N Exp.12/13, NAA05PC Exp.12/13, NAA0462 Exp.12/13", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "10 units", "code_info": "Rx #'s: 0390522, 0390522, 0353081, 0390522, 0390522, 0398989", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ACETAZOLAMIDE, LYOPHILIZED 500MG INJECTABLE10 VIAL, 4 VIAL, 5 VIAL, 6 VIAL, 8 VIAL (5 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1447-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "2 units", "code_info": "Rx #:  0398930", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "FOLIC ACID 10MG/ML INJECTABLE 60 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1521-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078765"], "brand_name": ["FOSPHENYTOIN SODIUM"], "generic_name": ["FOSPHENYTOIN SODIUM"], "manufacturer_name": ["West-Ward Pharmaceuticals Corp"], "product_ndc": ["0143-9782", "0143-9788"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["FOSPHENYTOIN SODIUM"], "rxcui": ["1670195", "1670200"], "spl_id": ["6b56fe59-9fb1-410b-b57c-7ada1662136a"], "spl_set_id": ["c92df63b-5140-4213-8d43-8327ff6230b7"], "package_ndc": ["0143-9788-01", "0143-9788-25", "0143-9782-01", "0143-9782-10", "0143-9704-25"], "is_original_packager": [true], "unii": ["7VLR55452Z"]}, "product_type": "Drugs", "event_id": "62627", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "All lots were distributed throughout the US.", "recall_number": "D-1437-2012", "product_description": "Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ  07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).", "product_quantity": "a) 308,275 vials; b) 2,008,850 vials", "reason_for_recall": "Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.", "recall_initiation_date": "20120413", "center_classification_date": "20120802", "termination_date": "20150116", "report_date": "20120808", "code_info": "Lot #s: a) 113153.1, 113154.1, 113155.1, Exp 05/13; 113248.1, Exp 07/13; b) 103196.1, 103197.1, 103197.2, 103198.1, Exp 07/12; 103317.1, 103318.1, 103319.1, 103345.1, 103345.2, Exp 11/12; 103346.1, 103347.1, 103348.1, 103349.1, 103350.1, Exp 12/12; 113030.1, 113031.1, 113032.1, 113033.1, 113034.1, 113035.1, 113036.1, Exp 01/13; 113245.1, 113246.1, 113247.1, Exp 07/13"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "4 units", "code_info": "Rx #'s:  0408599    0401410    0402367", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "METHYLPREDNISOLONE ACETATE/LIDOCAINE HCL 40MG/10MG/ML INJECTABLE\t100 ML  \t500 ML;  METHYLPREDNISOLONE/LIDOCAINE 80MG/10MG/ML INJECTABLE\t24 ML  (3 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1576-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Shirley", "address_1": "One Luitpold Drive", "reason_for_recall": "Presence of Particulate Matter", "address_2": "P.O. Box 9001", "product_quantity": "63,750 ampules", "code_info": "Lot #1395 Exp: July 2012", "center_classification_date": "20120716", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "Epinephrine Injection, USP, 1:1000 (1 mg/mL), 25 x 1 mL Ampules, For SC and IM Use, For IV and IC Use after Dilution,  Rx Only, American Regent, Inc., Shirely, NY 11967 --NDC 0517-1071-25", "report_date": "20120725", "classification": "Class II", "openfda": {}, "recalling_firm": "Luitpold Pharmaceuticals, Inc.", "recall_number": "D-1421-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "61714", "termination_date": "20170411", "more_code_info": "", "recall_initiation_date": "20120424", "postal_code": "11967-9001", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Buffalo Grove", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA076639"], "brand_name": ["CIPROFLOXACIN"], "generic_name": ["CIPROFLOXACIN"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-411", "16571-412", "16571-413"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CIPROFLOXACIN HYDROCHLORIDE"], "rxcui": ["197511", "197512", "309309"], "spl_id": ["f031ce92-a4ed-45b0-8eb3-c3bdb02fbece"], "spl_set_id": ["ef468722-68cd-440b-afd7-2285029db41f"], "package_ndc": ["16571-411-10", "16571-412-10", "16571-412-50", "16571-413-05"], "is_original_packager": [true], "upc": ["0316577411102", "0316571412501"], "unii": ["4BA73M5E37"]}, "product_type": "Drugs", "event_id": "51880", "recalling_firm": "Pack Pharmaceuticals", "address_1": "1110 W Lake Cook Rd", "address_2": "Ste 301", "postal_code": "60089-1944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1422-2012", "product_description": "Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.", "product_quantity": "4,848 bottles", "reason_for_recall": "Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.", "recall_initiation_date": "20120309", "center_classification_date": "20120719", "termination_date": "20120719", "report_date": "20120725", "code_info": "Lot #: : PUB1040, Exp 08/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "62383", "recalling_firm": "Watson Laboratories Inc", "address_1": "311 Bonnie Cir", "address_2": "N/A", "postal_code": "92880-2882", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1403-2012", "product_description": "Loxitane Capsules, Loxapine Succinate Capsules,  10mg base, 100 count bottle, Rx only,   Watson Laboratories Inc., Corona, CA 92880 NDC #  52544-495-01", "product_quantity": "7,262 bottles", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.", "recall_initiation_date": "20120417", "center_classification_date": "20120629", "termination_date": "20130318", "report_date": "20120711", "code_info": "Lot # 22478A"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020622"], "brand_name": ["COPAXONE"], "generic_name": ["GLATIRAMER ACETATE"], "manufacturer_name": ["Teva Neuroscience, Inc."], "product_ndc": ["68546-317", "68546-325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["GLATIRAMER ACETATE"], "rxcui": ["1111641", "1111642", "1487361", "1487363"], "spl_id": ["5a691b1f-367f-4635-a7d6-0111361a2dbb"], "spl_set_id": ["aa88f583-4f5f-433b-80b4-1f4c9fb28357"], "package_ndc": ["68546-317-00", "68546-317-30", "68546-325-06", "68546-325-12"], "is_original_packager": [true], "unii": ["5M691HL4BO"]}, "product_type": "Drugs", "event_id": "62241", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1442-2012", "product_description": "Copaxone (glatiramer acetate injection),  20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDC 68546-317-30", "product_quantity": "6,647 cartons", "reason_for_recall": "Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.", "recall_initiation_date": "20120518", "center_classification_date": "20120803", "termination_date": "20130411", "report_date": "20120815", "code_info": "Lot number X05011, Exp 08/13", "more_code_info": ""}]